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All	  amino	  acids	  were	  purchased	  from	  Aapptec	  as	  the	  FMOC	  carboxylic	  acid	  with	  the	  standard	  
TFA	  side-­‐chain	  protecting	  groups.	  	  HATU	  (2-­‐(7-­‐Aza-­‐1H-­‐benzotriazole-­‐1-­‐yl)-­‐1,1,3,3-­‐tetramethyluronium	  
hexafluorophosphate)	  and	  PEG5	  (Fmoc-­‐NH-­‐PEG5-­‐CH2CH2COOH,	  Fmoc-­‐18-­‐amino-­‐4,7,10,13,16-­‐
pentaoxaoctadecanoic	  acid)	  were	  purchased	  from	  ChemPep.	  	  DIEA	  (diisoproylethylamine),	  triethylsilane	  
(TES)	  and	  TFA	  (Trifluoroacetic	  acid)	  were	  purchased	  from	  Sigma.	  	  TentaGel	  beads	  were	  purchased	  as	  
90μm	  S-­‐NH2	  beads,	  0.29mmol/g,	  2.86x106	  beads/g	  from	  Rapp	  Polymere	  (Germany)	  and	  Rink	  Amide	  
resin	  was	  purchased	  from	  Anaspec.	  
	  
Peptide	  Library	  Construction	  
	   Peptide	  libraries	  were	  synthesized	  on	  a	  Titan	  357	  split-­‐and-­‐mix	  automated	  peptide	  synthesizer	  
(Aapptec)	  via	  standard	  FMOC	  SPPS	  coupling	  chemistry1	  using	  90μm	  TentaGel	  S-­‐NH2	  beads.	  	  Libraries	  
contain	  18	  D-­‐stereoisomers	  of	  the	  natural	  amino	  acids,	  minus	  Cysteine	  and	  Methionine,	  at	  each	  of	  five	  
randomized	  positions	  and	  an	  azide	  or	  alkyne	  in	  situ	  click	  handle.	  	  At	  least	  a	  five-­‐fold	  excess	  of	  beads	  is	  
used	  when	  synthesizing	  libraries	  to	  ensure	  oversampling	  of	  each	  sequence.	  	  Amino	  acid	  side-­‐chains	  are	  
protected	  by	  TFA	  labile	  protecting	  groups	  that	  are	  removed	  all	  at	  once	  following	  library	  synthesis.	  
	  
Bulk	  Peptide	  Synthesis	  
	   Bulk	  synthesis	  of	  peptide	  sequences	  was	  performed	  using	  standard	  FMOC	  SPPS	  peptide	  
chemistry	  on	  either	  the	  Titan	  357	  automated	  peptide	  synthesizer	  (AAPPTEC)	  or	  a	  Liberty	  1	  microwave	  
peptide	  synthesizer	  (CEM	  Corporation).	  	  The	  typical	  scale	  was	  300mg	  on	  Rink	  Amide	  Resin,	  unless	  
otherwise	  noted.	  	  Peptides	  were	  cleaved	  from	  the	  beads	  with	  deprotected	  side-­‐chains	  using	  a	  95:5:5	  
ratio	  of	  TFA:	  H2O:	  TES.	  	  The	  peptides	  were	  purified	  on	  a	  prep-­‐scale	  Dionex	  U3000	  HPLC	  with	  a	  reverse-­‐
phase	  C18	  column	  (Phenomenex).	  	  All	  peptides	  are	  checked	  for	  correct	  mass	  and	  impurities	  using	  
MALDI-­‐TOF	  MS	  and	  are	  lyophilized	  to	  a	  powder	  for	  long-­‐term	  storage	  at	  room	  temperature.	  	  
Concentrated	  peptide	  stocks	  for	  assays	  are	  made	  by	  dissolving	  powder	  in	  small	  amounts	  of	  DMSO	  and	  
measuring	  the	  A280	  absorbance	  via	  nanodrop	  to	  determine	  the	  stock	  concentration.	  
	  
Akt1	  Wildtype	  and	  E17K	  Mutant	  Pleckstrin	  Homology	  Domain	  Expression	  
	   Akt1	  Pleckstrin	  Homology	  Domain	  DNA	  was	  purchased	  from	  DNA2.0	  with	  codons	  optimized	  for	  
expression	  in	  E.coli.	  	  The	  first	  124	  N-­‐terminal	  amino	  acids	  from	  full	  length	  Akt1	  were	  used	  as	  the	  PH	  
Domain	  DNA,	  and	  a	  6-­‐his	  tag	  separated	  by	  a	  thrombin	  cleavage	  site	  were	  added	  at	  the	  C-­‐terminus	  of	  the	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protein	  for	  purification.	  	  In	  order	  to	  make	  the	  E17K	  mutant	  of	  the	  PH	  Domain,	  the	  glutamic	  acid	  in	  
position	  17	  was	  mutated	  to	  a	  lysine	  via	  QuikChange	  (Stratagene)	  following	  all	  of	  the	  manufacturer’s	  
protocols.	  	  The	  DNA	  was	  synthesized	  in	  a	  pJexpress	  414	  vector	  containing	  an	  ampicillin	  resistant	  gene	  to	  
be	  expressed	  in	  E.	  coli	  cells.	  	  Protein	  expression	  was	  performed	  by	  the	  Protein	  Expression	  Center	  at	  
Caltech	  using	  their	  standard	  bacterial	  expression	  protocol	  and	  purified	  via	  Ni-­‐NTA	  column.	  	  The	  proteins	  
expressed	  in	  this	  manner	  were	  used	  for	  the	  immunoprecipitation	  assays	  confirming	  the	  anchor	  binding	  
via	  immunoprecipitation	  assays	  and	  for	  the	  biligand	  screens.	  	  These	  PH	  Domain	  proteins	  were	  
unsuitable	  for	  long-­‐term	  storage	  under	  a	  large	  variety	  of	  tested	  conditions,	  so	  a	  GST	  tag	  was	  added	  to	  
hopefully	  improve	  the	  long	  term	  stability.	  	  	  
For	  that	  reason,	  the	  DNA	  from	  DNA	  2.0	  was	  amplified	  out	  of	  the	  pJExpress	  vector	  via	  
Polymerase	  Chain	  Reaction	  (PCR)	  to	  insert	  the	  restriction	  enzyme	  sites	  EcoRI	  and	  NotI	  for	  insertion	  into	  
a	  pGEX-­‐4T-­‐1	  vector	  containing	  a	  GST	  tag.	  The	  primers	  used	  were:	  
	  5’	  -­‐	  AGAGAATCCATGTCCGACGTCGCGATCGTAAAGGAAGGG	  –	  3’	  
5’	  -­‐	  TCTGCGGCCGCTTAGTGGTGATGATG	  –	  3’	  
Both	  the	  wildtype	  and	  E17K	  mutant	  DNA	  were	  amplified	  out	  of	  the	  pJExpress	  vector,	  restriction	  
enzyme	  digested,	  and	  ligated	  overnight	  into	  a	  pGEX-­‐4T-­‐1	  vector	  which	  attached	  an	  N-­‐terminal	  GST	  tag	  
to	  the	  PH	  Domain	  protein.	  	  BL21-­‐DE3-­‐pLys	  cells	  were	  transformed	  with	  the	  DNA,	  and	  the	  sequences	  
were	  confirmed	  via	  sequencing.	  	  An	  overnight	  starter	  colony	  from	  each	  of	  these	  plates	  was	  grown	  in	  
5mL	  LB+Amp	  overnight.	  	  4mL	  of	  this	  starter	  culture	  was	  used	  to	  inoculate	  500mL	  of	  LB+Amp	  and	  grown	  
to	  mid-­‐log	  phase.	  	  The	  cultures	  were	  inoculated	  with	  1mM	  IPTG	  and	  grown	  5	  hours	  at	  28°C.	  	  The	  cells	  
were	  centrifuged	  for	  10	  minutes	  at	  8,000RPM	  and	  lysed	  with	  lysis	  buffer	  (1x	  TBS,	  1mM	  DTT,	  1mg/mL	  
Lysozyme,	  1%	  Triton-­‐X),	  and	  left	  for	  30	  minutes	  on	  ice	  before	  flash	  freezing	  in	  liquid	  nitrogen.	  	  Upon	  
thawing	  on	  ice,	  the	  lysate	  was	  sonicated	  for	  5	  minutes,	  then	  centrifuged	  for	  30	  minutes	  at	  10,000	  RPM	  
to	  remove	  cellular	  debris.	  	  The	  supernatant	  was	  then	  purified	  on	  a	  HisPur	  Co	  column	  (Pierce)	  using	  the	  
manufacturer’s	  recommended	  protocol.	  	  These	  GST-­‐tagged	  proteins	  were	  used	  to	  confirm	  the	  biligand	  
binding	  via	  immunoprecipitation	  assays	  and	  for	  the	  triligand	  screens.	  	  They	  were	  also	  used	  to	  obtain	  the	  
full	  ELISA	  curves	  of	  all	  three	  ligands.	  	  These	  proteins,	  however,	  were	  also	  not	  suitable	  for	  long	  term	  
storage	  and	  needed	  to	  be	  re-­‐expressed	  for	  all	  assays.	  	  	  
The	  imaging	  experiments	  required	  that	  the	  PH	  Domain	  protein	  be	  expressed	  in	  mammalian	  cells	  
and	  have	  a	  GFP	  tag	  for	  visualization.	  	  Because	  of	  this,	  Akt1	  DNA	  with	  codons	  optimized	  for	  use	  in	  
mammalian	  cells	  was	  obtained	  from	  InvivoGen	  as	  a	  pUNO-­‐hAKT1	  plasmid.	  	  The	  DNA	  was	  mutated	  via	  
QuikChange	  so	  both	  a	  wildtype	  and	  E17K	  version	  were	  on	  hand.	  	  The	  primers	  used	  to	  clone	  the	  DNA	  
from	  this	  vector	  into	  a	  TOPO	  C-­‐terminal	  GFP	  mammalian	  vector	  were:	  	  
5’	  –	  AAGATGGGGATGAGCGACGTGGCT	  –	  3’	  
5’	  –	  TCCCCGACCGGAAGTCCATCTCCTC	  –	  3’.	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Cloning	  was	  done	  as	  per	  the	  TOPO	  vector	  manual.	  	  Because	  the	  GST-­‐PHD	  proteins	  expressed	  in	  
E.	  coli	  were	  still	  not	  stable	  for	  long	  term	  storage,	  this	  DNA	  was	  used	  to	  express	  the	  PHD	  in	  mammalian	  
cells.	  	  The	  expressions	  were	  done	  by	  transfecting	  a	  suspension	  culture	  of	  HEK-­‐293-­‐6E	  cells	  with	  
XtremeGene	  HD	  by	  the	  Protein	  Expression	  Center	  at	  Caltech	  following	  their	  standard	  protocols.	  	  These	  
proteins	  were	  not	  purified,	  and	  were	  used	  as-­‐is	  out	  of	  cell	  lysates.	  	  This	  protein	  was	  used	  in	  triligand	  
immunoprecipitation	  and	  inhibition	  assays,	  and	  was	  still	  not	  stable	  for	  long	  term	  storage.	  	  	  
	  
CD	  Spectroscopy	  of	  33-­‐mer	  Peptide	  Epitope	  
	   Lyophilized	  powder	  of	  the	  33-­‐mer	  biotin-­‐tagged	  target	  fragment	  that	  was	  used	  for	  screening	  
was	  dissolved	  in	  500μL	  of	  1x	  PBS	  to	  a	  concentration	  of	  0.5mg/mL.	  	  Concentrations	  were	  estimated	  by	  
weight	  and	  confirmed	  by	  A280	  measurement	  using	  NanoDrop.	  	  Experiments	  were	  performed	  using	  an	  
Aviv	  62	  CD	  Spectrometer.	  	  The	  machine	  was	  purged	  for	  20	  minutes	  with	  N2,	  then	  the	  1xPBS	  blank	  in	  a	  
500μL	  1cm	  cuvette	  was	  inserted	  and	  the	  machine	  was	  purged	  with	  N2	  for	  another	  5	  minutes.	  	  The	  
spectra	  was	  acquired	  by	  3	  measurements/minute	  from	  wavelengths	  199-­‐250nm.	  	  The	  33mer	  fragment	  
sample	  was	  then	  inserted,	  purged	  for	  5	  minutes,	  and	  was	  measured	  exactly	  as	  the	  blank.	  	  The	  33mer	  
cuvette	  was	  then	  removed,	  and	  500μL	  of	  7.0M	  pH	  =	  2.0	  Guanadine-­‐HCl	  was	  added	  to	  denature	  the	  
sample.	  	  This	  spectra	  was	  acquired	  as	  above.	  
	   To	  work	  up	  the	  data,	  the	  signal	  in	  ΔA	  from	  the	  sample	  was	  subtracted	  from	  the	  blank	  at	  each	  
wavelength.	  	  Then	  the	  mean	  residue	  molar	  circular	  dichroism	  ΔεMR	  was	  calculated	  from	  this	  readout	  
using	  the	  number	  of	  residues	  in	  the	  fragment	  (33)	  and	  the	  concentration	  in	  mg/mL	  (0.5	  for	  the	  folded	  
sample,	  0.25	  for	  the	  denatured	  sample	  since	  it	  was	  diluted	  with	  Guanadine-­‐HCl)	  using	  the	  equation:	  
ΔεMR=	  ΔA/((residue	  #	  x	  concentration	  mg/mL)	  x	  l)
2.	  	  The	  spectra	  were	  graphed	  by	  plotting	  this	  number	  
against	  the	  wavelength.	  	  As	  can	  be	  seen	  in	  Supplemental	  Figure	  S1,	  the	  CD	  signature	  for	  the	  33mer	  
peptide	  resembles	  that	  of	  a	  β–sheet,	  which	  was	  the	  expected	  structure	  based	  on	  the	  full	  protein	  crystal	  
structure.	  	  This	  binding	  disappeared	  upon	  the	  addition	  of	  the	  denaturing	  buffer,	  demonstrating	  that	  this	  
is	  a	  real	  structure	  in	  the	  33mer	  fragment.	  
Screen	  for	  Initial	  Anchor	  Peptide	  (Supplemental	  Figure	  S2)	  
	   Screens	  were	  performed	  using	  a	  library	  with	  100%	  Met	  coupled	  at	  the	  C-­‐terminus	  for	  potential	  
MALDI	  TOF/TOF	  sequencing3.	  	  The	  peptide	  library	  was	  a	  comprehensive	  5-­‐mer	  containing	  18	  unnatural	  
D-­‐amino	  acids,	  excluding	  Met	  and	  Cys	  due	  to	  stability	  reasons.	  	  The	  N-­‐terminus	  contained	  an	  azide	  click	  
handle	  with	  varying	  carbon	  chain	  lengths	  –	  2	  carbon,	  4	  carbon	  and	  8	  carbon	  –	  for	  in	  situ	  click	  with	  the	  
Pra	  on	  the	  target	  33-­‐mer-­‐epitope	  fragment.	  	  Screens	  were	  performed	  using	  300mg	  of	  dried	  library	  beads	  
swelled	  at	  least	  six	  hours	  in	  1x	  TBS	  (25mM	  Tris-­‐Cl,	  150mM	  NaCl,	  10mM	  MgCl2,	  pH	  =	  7.5)	  buffer.	  
Preclear	  (Supplemental	  Figure	  S2A):	  
	   Swelled	  library	  beads	  were	  blocked	  overnight	  in	  5%	  w/v	  dried	  non-­‐fat	  milk	  in	  1x	  TBS,	  then	  
washed	  with	  1x	  TBS	  three	  times.	  	  Five	  milliliters	  of	  a	  1:10,000	  dilution	  of	  streptavidin-­‐alkaline	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phosphatase	  conjugate	  in	  0.5%	  milk	  in	  TBS	  was	  added	  to	  the	  beads	  and	  incubated	  shaking	  at	  room	  
temperature	  for	  one	  hour.	  	  The	  beads	  were	  washed	  with	  a	  high-­‐salt	  TBS	  buffer	  (1x	  TBS	  with	  750mM	  
NaCl)	  three	  times,	  then	  let	  shake	  in	  high	  salt	  buffer	  for	  one	  hour.	  	  The	  beads	  were	  then	  washed	  three	  
times	  with	  BCIP	  buffer	  (100mM	  Tris-­‐Cl,	  150mM	  NaCl,	  1mM	  MgCl2,	  pH	  =	  9.0)	  and	  developed	  by	  adding	  
15mL	  BCIP	  buffer	  plus	  13μL	  BCIP	  and	  26μL	  NBT	  (two	  part	  system,	  Promega)	  	  After	  one	  hour,	  the	  purple	  
beads	  were	  removed	  by	  pipette	  and	  discarded.	  	  The	  remaining	  beads	  were	  incubated	  in	  NMP	  4	  hours	  to	  
remove	  trace	  purple	  precipitate	  from	  the	  BCIP/NBT	  reaction,	  then	  were	  washed	  five	  times	  with	  
methanol,	  five	  times	  with	  water,	  five	  times	  with	  TBS	  and	  reblocked	  overnight	  in	  5%	  milk.	  
Product	  Screen	  (Supplemental	  Figure	  S2B):	  
	   Beads	  remaining	  from	  the	  preclear	  were	  washed	  three	  times	  with	  1x	  TBS,	  then	  incubated	  with	  
5mL	  of	  a	  100nM	  dilution	  of	  the	  33-­‐mer	  target	  in	  0.5%	  milk	  for	  either	  5	  hours	  or	  12	  hours	  to	  allow	  for	  an	  
in	  situ	  click	  reaction	  to	  occur.	  	  The	  beads	  were	  then	  washed	  three	  times	  with	  1x	  TBS	  and	  incubated	  for	  
one	  hour	  with	  a	  7M	  Guanadine-­‐HCl	  buffer	  (pH	  =	  2.0)	  to	  remove	  all	  33-­‐mer	  target	  epitope	  not	  attached	  
covalently	  to	  the	  beads.	  	  These	  beads	  were	  then	  washed	  ten	  times	  with	  1x	  TBS,	  reblocked	  for	  two	  hours	  
in	  5%	  milk,	  then	  incubated	  for	  one	  hour	  with	  a	  1:10,000	  dilution	  of	  streptavidin-­‐	  alkaline	  phosphatase	  
conjugate	  in	  0.5%	  milk	  in	  TBS	  to	  detect	  for	  the	  presence	  of	  the	  33-­‐mer	  target	  epitope	  clicked	  to	  a	  bead.	  	  
The	  beads	  were	  washed	  three	  times	  with	  a	  high-­‐salt	  TBS	  buffer,	  then	  let	  shake	  in	  high	  salt	  buffer	  for	  one	  
hour.	  	  Afterwards,	  the	  beads	  were	  again	  washed	  three	  times	  in	  BCIP	  buffer	  and	  developed	  as	  per	  the	  
preclear.	  	  Purple	  beads	  are	  removed	  from	  the	  screen	  via	  pipette	  as	  hit	  beads.	  	  These	  hits	  were	  incubated	  
in	  the	  guanidine-­‐HCl	  buffer	  to	  remove	  attached	  streptavidin,	  washed	  ten	  times	  with	  water	  and	  
sequenced	  via	  edman	  degradation	  on	  a	  Procise	  CLC	  system	  from	  Applied	  Biosystems.	  	  See	  Table	  S1	  for	  
sequences	  from	  5	  hour	  screen,	  Table	  S2	  for	  sequences	  from	  16	  hour	  screen.	  
	   All	  hit	  ratios	  were	  determined	  by	  dividing	  the	  number	  of	  hit	  beads	  from	  the	  number	  of	  beads	  
present	  in	  the	  screen	  as	  determined	  by	  the	  mass	  of	  the	  screened	  library.	  	  Hit	  sequences	  that	  could	  not	  
be	  accurately	  called	  via	  Edman	  degradation	  were	  still	  included	  in	  this	  calculation,	  but	  were	  not	  scaled	  up	  
and	  tested	  as	  potential	  candidates.	  
	  
Sequence	  Analysis	  
	   Hit	  sequences	  were	  analyzed	  via	  a	  peptide	  analysis	  algorithm	  that	  organized	  hits	  based	  on	  their	  
hydrophobicity	  and	  sequence	  homology	  using	  principal	  component	  analysis.	  	  The	  algorithm	  analyzes	  a	  
series	  of	  peptides	  and	  graphs	  them	  on	  a	  2D	  sequence	  map.	  	  Clusters	  of	  hits	  were	  circled	  (Supplemental	  
Figure	  S3),	  and	  one	  peptide	  from	  each	  cluster	  was	  scaled-­‐up	  and	  tested	  for	  binding	  to	  both	  wildtype	  and	  
mutant	  PH	  domain.	  	  The	  ligands	  chosen	  for	  scale	  up	  were:	  dqntr,	  ypwve,	  eefef,	  yleaf,	  and	  elnhy.	  	  Any	  
ligand	  candidates	  that	  were	  difficult	  to	  call	  on	  the	  sequencing	  were	  not	  chosen	  for	  scale-­‐up	  and	  testing.	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Streptavidin	  –	  Agarose	  Immunoprecipitation	  Assays	  for	  Binding	  Affinity	  
	   Immunoprecipitation	  assays	  were	  done	  on	  Streptavidin	  Agarose	  resin	  from	  Invitrogen.	  	  The	  resin	  
was	  incubated	  in	  SpinX	  tubes	  (Sigma)	  for	  one	  hour	  with	  an	  excess	  of	  N-­‐terminal	  biotinylated	  anchor	  
peptide	  candidates	  identified	  via	  principle	  component	  analysis.	  	  The	  anchor	  candidate	  coated	  beads	  
were	  then	  blocked	  for	  one	  hour	  with	  5%	  BSA	  in	  TBS,	  then	  incubated	  with	  either	  the	  wildtype	  or	  mutant	  
protein	  overnight	  at	  4C.	  	  The	  protein	  solutions	  were	  spun	  out,	  and	  the	  resins	  were	  washed	  3x	  with	  
1xTBS	  +	  0.1%	  Tween-­‐20,	  3x	  high-­‐salt	  TBS,	  and	  1x	  TBS	  before	  being	  spun	  dry	  and	  bound	  proteins	  were	  
eluted	  by	  boiling	  for	  10	  minutes	  in	  50uL	  SDS-­‐PAGE	  gel	  loading	  buffer.	  	  The	  eluted	  proteins	  were	  
separated	  by	  SDS-­‐PAGE	  gel,	  and	  western	  blotted	  for	  the	  presence	  of	  PH	  Domain	  protein.	  
Relative	  protein	  band	  sizes	  were	  analyzed	  to	  compare	  binding	  between	  the	  anchor	  candidates	  
and	  were	  used	  to	  determine	  selectivity	  for	  either	  wildtype	  or	  mutant	  PH	  Domain	  (Supplemental	  Figure	  
S4).	  	  For	  selective	  binding	  to	  the	  E17K	  mutant	  protein,	  yleaf	  was	  chosen,	  as	  it	  showed	  the	  greatest	  
binding	  to	  the	  mutant	  with	  the	  least	  binding	  to	  the	  wildtype.	  
	  
Point	  ELISAs	  with	  Anchor	  Ligand	  and	  33-­‐mer	  Epitope	  –	  Epitope	  Targeting	  Verification	  
	   The	  33-­‐mer	  epitope	  used	  in	  screening	  was	  resynthesized	  without	  the	  alkyne	  click	  handle	  and	  
with	  a	  6-­‐His	  tag	  as	  an	  orthogonal	  tag	  to	  the	  biotin	  on	  the	  anchor	  ligand.	  	  This	  tag	  was	  added	  after	  a	  PEG5	  
on	  the	  N-­‐terminus	  of	  the	  peptide,	  and	  was	  made	  and	  purified	  as	  was	  previously	  described	  
(Supplemental	  Figure	  S24	  and	  Supplemental	  Figure	  S25).	  
	   For	  these	  assays,	  100nM	  Biotin-­‐PEG5-­‐yleaf	  (Supplemental	  Figure	  S26)	  was	  immobilized	  for	  one	  
hour	  on	  a	  Neutravidin-­‐coated	  ELISA	  plate	  (Pierce).	  	  The	  plate	  was	  blocked	  in	  5%	  BSA	  in	  1xTBS	  overnight	  
at	  room	  temperature.	  	  The	  immobilized	  anchor	  was	  then	  incubated	  with	  either	  1μM	  or	  100nM	  wildtype	  
33-­‐mer	  epitope	  or	  1μM	  or	  100nM	  E17K	  mutant	  33-­‐mer	  epitope	  for	  one	  hour.	  	  The	  plate	  was	  washed	  
three	  times	  with	  1xTBS	  +	  0.1%	  Tween-­‐20	  and	  tapped	  dry.	  	  The	  epitope	  was	  then	  detected	  by	  a	  1:1,000	  
dilution	  of	  an	  anti-­‐his	  mouse	  mAb	  (ab18184,	  Abcam)	  for	  one	  hour,	  washed	  as	  above,	  and	  then	  detected	  
with	  1:10,000	  dilution	  of	  an	  anti-­‐mouse	  HRP-­‐conjugated	  goat	  pAb	  (Abcam)	  for	  one	  hour.	  	  The	  plate	  was	  
once	  again	  washed	  and	  developed	  with	  a	  1:1	  TMB	  substrate	  (KMB)	  for	  15	  minutes.	  	  To	  graph	  the	  data,	  
the	  blank	  (epitope	  and	  antibodies	  binding	  to	  plate	  with	  no	  anchor	  ligand	  present)	  was	  subtracted	  from	  
the	  triplicate	  sample	  values.	  	  The	  fraction	  bound	  was	  found	  by	  setting	  the	  highest	  value	  to	  100%	  and	  
normalizing	  the	  rest	  accordingly.	  	  The	  triplicate	  values	  were	  then	  graphed	  (Fig.	  2c)	  with	  their	  error	  bars	  
and	  the	  p-­‐values	  were	  calculated	  by	  GraphPad.	  
	  
HPLC-­‐detected	  Immunoprecipitation	  Assays	  –	  Epitope	  Targeting	  Verification	  
	   Immunoprecipitation	  assays	  with	  the	  biotinylated	  anchor	  and	  his-­‐tagged	  33-­‐mer	  epitope	  were	  
performed	  to	  verify	  epitope	  targeting.	  	  In	  these	  assays,	  biotinylated	  anchor	  ligand	  was	  used	  to	  pull	  the	  
WT	  or	  E17K	  mutant	  fragments	  from	  solution.	  	  As	  with	  the	  full-­‐protein	  assays,	  the	  biotinylated	  anchor	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ligand	  was	  incubated	  for	  one	  hour	  with	  50μL	  of	  streptavidin	  agarose	  slurry	  that	  had	  been	  washed	  three	  
times	  with	  1xTBS.	  	  The	  anchor	  ligand	  was	  washed	  out,	  and	  the	  resin	  was	  blocked	  for	  an	  hour	  in	  5%	  BSA	  
in	  1xTBS.	  	  200μL	  of	  a	  50μM	  solution	  of	  the	  His-­‐tagged	  33-­‐mer	  epitope	  in	  1xTBS	  was	  added	  to	  the	  
blocked	  resin	  and	  this	  was	  incubated	  overnight	  (~16	  hours)	  at	  4°C.	  	  Because	  small	  peptide	  fragments	  like	  
the	  33-­‐mer	  epitope	  are	  difficult	  to	  transfer	  to	  and	  detect	  on	  the	  nitrocellulose	  membrane	  as	  for	  a	  
traditional	  Western	  blot,	  the	  amount	  of	  binding	  in	  these	  assays	  was	  detected	  via	  HPLC.	  	  In	  order	  to	  do	  
this,	  the	  bound	  33-­‐mer	  peptide	  fragments	  were	  washed	  three	  times	  with	  1xTBS	  +	  0.5%	  BSA	  and	  one	  
time	  with	  1xTBS.	  	  The	  resin	  was	  then	  incubated	  with	  200μL	  of	  the	  7M	  pH	  =	  2.0	  Guanadine-­‐HCl	  buffer	  
used	  to	  strip	  beads	  in	  the	  screen.	  	  The	  Guanidine	  buffer	  was	  spun	  out	  of	  the	  beads	  in	  Spin-­‐X	  tubes	  and	  
injected	  onto	  a	  Beckman	  Coulter	  semi-­‐prep	  HPLC	  with	  an	  analytical	  scale	  reverse	  phase	  C18	  analytical	  
column.	  	  The	  peak	  seen	  on	  the	  HPLC	  (Supplemental	  Figure	  S5)	  illustrated	  how	  much	  of	  the	  33-­‐mer	  
epitope	  bound	  to	  either	  the	  yleaf	  anchor	  or	  to	  blank	  beads.	  
	   These	  assays	  in	  conjunction	  with	  the	  point	  ELISAs	  described	  above	  demonstrate	  the	  binding	  of	  
the	  anchor	  ligand	  to	  the	  epitope	  that	  was	  used	  for	  screening	  in	  a	  variety	  of	  different	  conditions.	  	  The	  
results	  conclusively	  demonstrate	  that	  the	  yleaf	  anchor	  not	  only	  binds	  to	  the	  epitope	  fragment,	  but	  is	  
selective	  for	  the	  single	  amino	  acid	  E17K	  mutation	  on	  both	  the	  full	  protein	  and	  fragment.	  
Ligand-­‐Directed	  Tosylate	  Labeling	  Experiments	  
	   For	  these	  assays,	  the	  yleaf	  anchor	  on	  a	  C-­‐terminal	  CPP	  was	  appended	  with	  an	  N-­‐terminal	  FMOC-­‐
piperidine-­‐4-­‐carboxylic	  acid	  as	  a	  linker	  on	  300mg	  of	  rink	  amide	  resin	  in	  NMP	  using	  standard	  FMOC	  
amino	  acid	  coupling	  techniques.	  	  The	  resin	  was	  equilibrated	  in	  anhydrous	  DCM	  and	  250μL	  of	  3-­‐
(chlorosulfonyl)benzylchloride	  was	  added	  with	  450μL	  of	  DIEA	  and	  shook	  for	  30	  minutes	  at	  room	  
temperature.	  	  Then	  250μL	  of	  2-­‐(2-­‐(2-­‐aminoethoxy)ethoxy)ethanol,	  450μL	  of	  DIEA	  and	  19mg	  DMAP	  in	  
anhydrous	  DMC	  were	  added	  and	  shook	  overnight.	  	  The	  resin	  was	  washed	  and	  equilibrated	  in	  NMP	  and	  
2eq	  Cy5	  carboxylic	  acid	  (Lumiprobe)	  was	  coupled	  at	  37°C	  overnight	  using	  standard	  FMOC	  coupling	  
techniques.	  	  The	  resin	  was	  washed,	  TFA	  cleaved	  and	  HPLC	  purified	  as	  usual.	  
	   In	  order	  to	  label	  the	  protein,	  50μL	  of	  full-­‐length	  GST-­‐E17K	  Akt1	  from	  SignalChem	  was	  treated	  
with	  10x	  molar	  excess	  of	  the	  anchor	  ligand	  with	  the	  tosylate	  dye	  label	  and	  incubated	  for	  two	  days	  at	  
room	  temperature.	  	  The	  10x	  excess	  required	  was	  determined	  through	  a	  separate	  experiment	  in	  which	  
1x,	  4x,	  and	  10x	  quantities	  of	  labeling	  arm	  with	  biotin	  label	  were	  incubated	  with	  the	  protein	  and	  blotted	  
for	  the	  presence	  of	  biotin.	  	  The	  results	  of	  this	  gel	  and	  labeling	  experiment	  can	  be	  seen	  in	  Supplemental	  
Figure	  S7.	  	  The	  mixture	  was	  lyophilized	  after	  two	  days	  and	  then	  denatured	  by	  boiling	  in	  SDS-­‐PAGE	  
loading	  buffer.	  	  The	  labeled	  protein	  was	  run	  alongside	  an	  unlabeled	  control	  on	  an	  Any-­‐KD	  gel	  from	  
Biorad,	  then	  imaged	  on	  an	  Odyssey	  fluorescent	  gel	  reader	  at	  700nm	  emission	  (Fig.	  3b).	  	  After	  confirming	  
that	  labeling	  had	  occurred,	  the	  gel	  was	  stained	  with	  BioSafe	  Coomassie	  blue	  stain	  (BioRad)	  and	  the	  blue	  
protein	  bands	  were	  cut	  out.	  	  The	  gel	  pieces	  were	  trypsin	  digested	  using	  the	  Pierce	  In-­‐gel	  Digest	  Kit.	  	  The	  
tryptic	  fragments	  from	  both	  the	  unlabeled	  and	  labeled	  protein	  digests	  were	  lyophilized	  to	  concentrate	  
them,	  taken	  up	  in	  2μL	  of	  50%	  H2O/50%	  acetonitrile	  and	  were	  analyzed	  by	  MALDI-­‐TOF	  MS	  (Supplemental	  
Figure	  S8	  and	  Figure	  S9).	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   Initially,	   analyses	  were	  performed	  by	   taking	   any	  peak	   that	  was	  present	   in	   the	   labeled	  protein	  
sample	   that	  was	   not	   present	   in	   the	   unlabeled	   sample.	   	   The	  weight	   of	   the	   dye	   labeling	   arm	   –	   552.37	  
g/mol	   –	  was	   subtracted	   from	   these	   peaks	   and	   the	   corresponding	   tryptic	   fragment	  was	   located.	   	   This	  
provided	   four	  potential	   fragment	   candidates	   that	  were	  all	   located	  near	   the	  33-­‐mer	  epitope	   in	   the	  PH	  
domain	  of	  the	  protein.	  	  Next,	  every	  MALDI	  peak	  in	  the	  labeled	  sample	  was	  analyzed	  by	  subtracting	  the	  
weight	  of	  the	  dye	  label	  and	  comparing	  it	  to	  a	  potential	  tryptic	  fragment	  (Supplemental	  Table	  S3).	  	  One	  
other	  fragment	  was	  identified	  using	  this	  method,	  and	  corresponded	  to	  the	  doubly	  labeled	  peak	  of	  one	  of	  
the	   previously	   identified	   labeled	   fragments.	   	   These	   results	   confirmed	   multiple	   previous	   experiments	  
done	   using	   LC/MS	   techniques	   that	   proved	   not	   strong	   enough	   to	   fragment	   the	   tryptic	   peptides	   into	  
individual	  amino	  acids.	  
	   These	  tryptic	  peptide	  samples	  were	  then	  analyzed	  by	  MALDI-­‐TOF/TOF	  MS	  to	  identify	  the	  exact	  
amino	   acid	   that	   contained	   the	   dye	   label.	   	   Only	   YFLLK	   was	   able	   to	   be	   successfully	   fragmented	  
(Supplemental	   Figure	   S10),	   and	   the	   TOF/TOF	   confirmed	   that	   the	   tyrosine	   was	   the	   label-­‐containing	  
amino	  acid.	  	  This	  confirms	  the	  results	  seen	  in	  the	  original	  publication4	  that	  only	  Y,	  H,	  and	  E	  nucleophilic	  
amino	  acids	  are	  labeled	  using	  this	  technique.	  	  The	  remaining	  tryptic	  fragments	  all	  contain	  at	  least	  one	  of	  
these	  amino	  acids,	  with	  the	  double	  labeled	  fragment	  containing	  two.	  
	   The	   labeling	   sites	   were	   then	   plotted	   onto	   a	   Pymol	   image	   (Fig.	   3c)	   that	   combined	   the	   Akt1	  
protein	  (PDB:	  3096)	  and	  the	  E17K	  PH	  Domain	  (PDB:	  2UZR)	  with	  the	  N-­‐terminal	  GST	  tag	  (PDB:	  1UA5)	  that	  
was	   present	   on	   the	   full-­‐length	   protein	   from	   SignalChem	   that	  was	   used	   in	   these	   labeling	   assays.	   	   This	  
Pymol-­‐made	   fusion	   protein	   was	   used	   to	   approximate	   what	   the	   commercial	   protein	   looked	   like	   in	  
solution	  and	  give	  an	  idea	  of	  the	  extent	  of	  the	  selectivity	  of	  this	  assay.	  	  The	  concentration	  of	  labeling	  sites	  
only	  surrounding	  the	  epitope	  demonstrate	  the	  exclusive	  binding	  of	  this	  ligand	  in	  solution.	  
	  
Details	  on	  Tryptic	  Fragment	  Workup	  for	  Labeling	  Experiment	  
	   All	   of	   the	  peaks	   from	   the	  MALDI-­‐TOF	   spectra	   of	   the	   labeled	   tryptic	   digests	  were	   analyzed	   for	  
their	  potential	   to	  contain	  a	  dye	   label.	   	  The	  MALDI	  spectra	  was	  manually	  calibrated	  to	  ensure	  the	   least	  
possible	   error.	   	   Each	   peak	   was	   then	   analyzed	   by	   zooming	   in	   on	   the	   spectra	   on	   the	   computer	   and	  
obtaining	  the	  exact	  mass	  for	  the	  monoisotopic	  peak,	  which	  is	  recorded	  as	  “MALDI	  peak”	  in	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Table	  S3	  below.	  	  The	  mass	  of	  the	  dye,	  552.37g/mol,	  was	  subtracted	  from	  this	  peak,	  and	  it	  was	  compared	  
to	  the	  closest	  possible	  theoretical	  tryptic	  digest	  fragment	  (“Digest”).	  	  The	  “expected”	  mass	  of	  the	  digest	  
plus	   the	  dye	  was	  calculated	  and	  subtracted	   from	  the	  observed	  mass,	  “MALDI	  peak”,	  and	  the	  absolute	  
value	  of	  this	  difference	  was	  recorded	  in	  “P/M	  1”.	  	  The	  peak	  area	  was	  obtained	  from	  the	  MALDI	  data	  and	  
added	   to	   the	   spreadsheet	   as	   “Peak	  Area”	   to	   allow	   for	   a	   cutoff	   (4500)	  of	   any	  peaks	   that	   looked	   to	  be	  
within	   the	   noise.	   	   Any	   peak	   below	   this	   value	   is	   shown	   in	   red	   italics,	   and	  was	   not	   considered	   for	   this	  
study.	   	  Any	  peak	  that	  was	  within	  0.1%	  of	   the	  mass	  of	   the	  expected	  digest	  mass	  was	  considered	  to	  be	  
within	   error	   of	   the	   instrument	   and	  was	   considered	   a	   hit	   dye-­‐labeled	   fragment.	   	   There	   were	   no	   new	  
peaks	   seen	   using	   this	   method	   than	   were	   discovered	   by	   looking	   for	   peaks	   that	   grew	   in	   from	   the	  
unlabeled	  MALDI	  to	  the	  labeled	  MALDI.	   	  The	  labeled	  sites	  seen	  in	  this	  MALDI-­‐TOF	  experiment	  were	  all	  
seen	  previously	  in	  at	  least	  2	  LC/ESI-­‐MS	  experiments	  attempting	  to	  identify	  the	  labeled	  region.	  
	   The	   peak	   at	   ~2212	   was	   not	   seen	   on	   the	   unlabeled	   mass	   spec,	   but	   is	   seen	   on	   the	   labeled	  
fragment	  and	  was	  considered	  a	  hit.	  	  2211	  is	  also,	  however,	  a	  common	  mass	  seen	  for	  trypsin.	  	  We	  do	  see	  
this	   particular	   unlabeled	   fragment	   fly	   in	   the	   MALDI-­‐TOF	   MS	   (1659),	   and	   know	   from	   the	   ESI-­‐MS	  
experiments	  that	  this	  is	  a	  site	  that	  can	  be	  labeled.	  	  In	  attempting	  to	  zoom	  in	  for	  the	  monoisotopic	  mass,	  
we	   see	   a	   broad	   peak	   with	   no	   clearly	   identifiable	   mass	   peak	   –	   unlike	   all	   of	   the	   other	   peaks	   in	   the	  
spectrum	  which	  showed	  the	  distribution	  of	  masses	  very	  clearly.	  	  This	  lead	  us	  to	  believe	  that	  we	  are,	  in	  
fact,	  seeing	  this	  peak	  labeled	  in	  the	  MALDI,	  especially	  as	  this	  site	  was	  seen	  as	  labeled	  by	  the	  ESI.	  	  The	  ESI	  
labeling	  experiments	  were	  also	  done	  using	  a	  labeling	  arm	  containing	  biotin	  and	  not	  Cy5,	  so	  this	  mass	  did	  
not	  overlap	  with	  trypsin	  in	  these	  experiments.	  	  We	  just	  cannot	  exactly	  call	  this	  mass	  in	  the	  MALDI	  due	  to	  
the	  similarity	  of	  this	  peak	  to	  that	  of	  trypsin.	  
	  
Images	  of	  anchor	  ligand	  in	  HEK-­‐293T	  cells	  expressing	  PH	  Domains	  
	   These	  experiments	  were	  designed	  to	  visualize	  the	  dye-­‐labeled	  anchor	  ligand	  in	  cells	  overlapping	  
with	  the	  GFP-­‐labeled	  PH	  Domain	  proteins.	  	  For	  this	  reason,	  the	  yleaf	  anchor	  ligand	  was	  synthesized	  with	  
an	  N-­‐terminal	  PEG5,	  TAT	  (YGRKKRRQRR),	  and	  Cy5	  dye	  (Fig.	  2a).	  	  GFP-­‐tagged	  protein	  DNA	  was	  also	  cloned	  
as	   described	   above.	   	   HEK-­‐293T	   cells	  were	   grown	   in	   DMEM	  media	   supplemented	  with	   10%	   FBS	   (both	  
Invitrogen),	  100x	  non-­‐essential	  amino	  acid	  solution	  (Sigma),	  and	  PenStrep	  antibiotic	  (Invitrogen).	  	  Once	  
the	  cells	   reached	  ~80%	  confluency,	   they	  were	  treated	  with	  trypsin	  to	  remove	  from	  the	  plate	  and	  split	  
into	   small	   wells	   with	   a	   D-­‐poly-­‐lysine	   (BD)	   coverslip	   at	   approximately	   a	   50%	   confluency	   in	   1mL	   total	  
volume.	   	   The	   cells	   were	   allowed	   to	   attach	   to	   the	   coverslips	   for	   approximately	   24	   hours,	   then	   were	  
transfected	   to	  express	  either	  wildtype	  GFP-­‐PH	  domain	  or	  E17K	  mutant	  GFP-­‐PH	  domain	  proteins	  using	  
XtremeGene	  HD	  transfection	  agent	  at	  a	  ratio	  of	  3:1	  transfection	  agent	  to	  DNA.	  	  Several	  wells	  were	  left	  
untreated	  as	  no	  protein	  blanks	   (Supplemental	   Figure	  S14).	   	   The	   cells	  were	   given	  24	  hours	   to	  express	  
protein.	   	  They	  were	  then	  serum	  starved	  for	  one	  hour	  in	  DMEM	  media	  prepared	  as	  above,	  but	  without	  
the	   FBS.	   	   After	   one	   hour,	   the	   Cy5-­‐labeled	   anchor	  was	   added	   to	   the	  wells	   to	   a	   final	   concentration	   of	  
50nM.	   	  As	  the	  HEK-­‐293T	  cells	  are	  expressing	  endogenous	  Akt1	  protein,	   this	   level	  was	  adjusted	  to	  give	  
the	   lowest	  background	  signal	  possible.	   	  The	  protein	  blank	  cells	  were	  also	   incubated	  with	  50nM	  of	   the	  
yleaf	  anchor	  to	  ensure	  that	  binding	  was	  due	  to	  the	  presence	  of	  the	  E17K	  mutant	  protein	  (Supplemental	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Figure	   S14).	   	   A	   blank	   of	   PEG5-­‐TAT-­‐Cy5	   was	   also	   added	   to	   wells	   expressing	   either	   wildtype	   or	   E17K	  
mutant	   to	  ensure	   that	   ligand	  binding	  was	  due	   to	   the	  presence	  of	   the	  yleaf	   anchor.	   	  After	   a	  one	  hour	  
incubation	  with	  the	  peptide,	   the	  cells	  were	  washed	  once	   in	  serum	  starved	  media,	   then	   incubated	  one	  
hour	   in	   serum	   starved	   media	   to	   wash	   out	   any	   excess	   peptide	   (see	   Supplemental	   Figure	   S13	   for	   a	  
comparison	  of	  peptide	  with	  and	  without	  the	  one	  hour	  wash	  step).	  	  During	  this	  time,	  the	  cells	  were	  also	  
treated	  with	  10μg	  of	  Hoescht	  33342	  dye	  to	  stain	  the	  nuclei.	  	  The	  cells	  were	  then	  washed	  twice	  with	  cold	  
PBS	  buffer,	  fixed	  with	  10%	  Neutral	  Buffered	  Formalin	  Solution	  (Sigma)	  and	  glued	  onto	  microscope	  slides.	  	  
Images	  were	  taken	  on	  a	  Zeiss	  LSM	  510	  Meta	  NLO	  with	  Coherent	  Chameleon	  confocal	  microscope.	  	  A	  40x	  
Plan-­‐apochromat	  lens	  was	  used.	  	  The	  laser	  intensity	  and	  gain	  were	  fixed	  for	  all	  pairs	  of	  images	  between	  
wildtype	  and	  mutant	  samples	  to	  ensure	  that	  the	  differences	  seen	  were	  not	  artificially	  created.	  
	   The	   images	   were	   analyzed	   by	   calculating	   the	   Pearson	   correlation	   coefficient	   in	   order	   to	  
determine	  the	  degree	  of	  co-­‐localization	  of	  the	  GFP-­‐tagged	  proteins	  and	  the	  Cy5	  anchor	   ligand	   in	  cells.	  	  
These	  calculations	  were	  performed	  by	  importing	  the	  images	  into	  ImageJ	  and	  splitting	  the	  channels.	  	  The	  
red	   and	   green	   channels	   were	   then	   analyzed	   for	   their	   Pearson	   coeeficient	   using	   the	   Just	   Another	  
Colocalization	  Plugin	  (JACoP).	  	  Four	  representative	  images	  for	  each	  protein	  were	  analyzed	  and	  averaged	  
to	  determine	   the	   final	   reported	   correlation	   coefficient.	   	   The	  values	   for	   these	  WT	   images	  were:	  0.213,	  
0.090,	  0.080,	  and	  0.19.	  	  The	  values	  for	  the	  E17K	  images	  were:	  0.448,	  0.305,	  0.674,	  and	  0.434.	  	  The	  final	  
values	  were	  determined	  to	  be	  r	  =	  0.143	  ±	  0.059	  for	  the	  WT	  and	  r	  =	  0.464	  ±	  0.133	  for	  the	  E17K	  mutant,	  
and	  are	  statistically	  significant	  (p	  =	  0.0045).	  
The	  unwashed	   images	   in	  Supplemental	   Figure	  S13	  were	  made	  using	  HEK-­‐293T	  cells	  grown	  on	  
coverslips	  expressing	  WT	  and	  E17K	  protein	  as	  described	  previously.	   	  The	  cells	  were	  serum	  starved	   for	  
one	  hour,	   then	   incubated	  with	  500nM	  ligand	   for	  one	  hour.	   	  The	  cells	  were	  then	  washed	  twice	   in	  cold	  
TBS	  buffer	  and	  fixed	  as	  described	  previously.	  
	  
Screen	  for	  Biligand	  Peptide	  (Supplemental	  Figure	  S16)	  
	   The	  anchor	  ligand	  determined	  above	  –	  yleaf	  –	  was	  scaled	  up	  with	  a	  biotin	  on	  the	  N-­‐terminus	  for	  
detection,	  a	  PEG5	   linker	  between	   the	  biotin	  and	   the	  peptide,	  and	  a	  d-­‐propargylglycine	   (Pra)	  on	   the	  C-­‐
terminus	   as	   the	   in	   situ	   click	   handle	   (Biotin-­‐PEG5-­‐yleaf-­‐Pra,	   Supplemental	   Figure	   S26).	   	   Screens	   were	  
done	  using	  a	  library	  with	  100%	  Met	  coupled	  at	  the	  C-­‐terminus	  for	  potential	  MALDI	  TOF/TOF	  sequencing.	  	  
The	  library	  consisted	  of	  a	  comprehensive	  5-­‐mer	  containing	  18	  unnatural	  D-­‐amino	  acids,	  excluding	  Met	  
and	  Cys	  due	  to	  stability	  reasons.	  	  The	  N-­‐terminus	  contained	  an	  azide	  click	  handle	  with	  a	  4	  carbon	  chain	  
(Lys(N3))–	  for	  in	  situ	  click	  with	  the	  Pra	  on	  the	  anchor	  peptide.	  	  Screens	  used	  300mg	  of	  dried	  library	  beads	  
swelled	  at	  least	  six	  hours	  in	  1x	  TBS	  (25mM	  Tris-­‐Cl,	  150mM	  NaCl,	  10mM	  MgCl2,	  pH	  =	  7.5)	  buffer.	  
Preclear	  (Supplemental	  Figure	  S16A):	  
	   Swelled	   library	   beads	   were	   blocked	   overnight	   in	   5%	   w/v	   dried	   non-­‐fat	   milk	   in	   1x	   TBS,	   then	  
washed	   with	   1x	   TBS	   three	   times.	   	   The	   beads	   were	   incubated	   with	   a	   7.15μM	   solution	   of	   the	   anchor	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peptide	  –	  Biot	  –	  PEG5	  –	  yleaf	  –	  Pra	  for	  one	  hour	  then	  washed	  three	  times	  with	  1xTBS.	  	  Five	  milliliters	  of	  a	  
1:10,000	  dilution	  of	  streptavidin-­‐alkaline	  phosphatase	  conjugate	   in	  0.5%	  milk	   in	  TBS	  was	  added	  to	  the	  
beads	  and	  incubated	  with	  shaking	  at	  room	  temperature	  for	  one	  hour.	   	  The	  beads	  were	  washed	  with	  a	  
high-­‐salt	  TBS	  buffer	   (1x	  TBS	  with	  750mM	  NaCl)	   three	   times,	   then	   let	   shake	   in	  high	   salt	  buffer	   for	  one	  
hour.	   	  The	  beads	  were	  then	  washed	  three	  times	  with	  BCIP	  buffer	   (100mM	  Tris-­‐Cl,	  150mM	  NaCl,	  1mM	  
MgCl2,	  pH	  =	  9.0)	  and	  developed	  by	  adding	  15mL	  BCIP	  buffer	  plus	  13μL	  BCIP	  and	  26μL	  NBT.	   	  After	  one	  
hour,	  the	  purple	  beads	  were	  removed	  by	  pipette	  and	  discarded.	  	  The	  remaining	  beads	  were	  incubated	  in	  
NMP	  four	  hours	  to	  remove	  trace	  purple	  precipitate	  from	  the	  BCIP/NBT	  reaction,	  then	  were	  washed	  five	  
times	  with	  methanol,	  five	  times	  with	  water,	  five	  times	  with	  TBS.	  
Target	  Screen	  (Supplemental	  Figure	  S16B):	  
	   The	  clear	  beads	  remaining	  from	  the	  preclear	  were	  blocked	  in	  5%	  milk	   in	  1x	  TBS	  for	  two	  hours.	  	  
They	   were	   then	   washed	   three	   times	   with	   1x	   TBS.	   	   A	   pre-­‐incubated	   solution	   of	   E17K	  mutant	   protein	  
(715nM)	  and	  anchor	   ligand	  (7.15μM)	   in	  3mL	  of	  0.5%	  milk	  was	  added	  to	  the	  blocked	   library	  beads	  and	  
incubated	  for	  either	  5	  hours	  or	  overnight	  to	  allow	  an	  in	  situ	  click	  reaction	  to	  occur.	  	  In	  the	  morning,	  the	  
beads	   were	   washed	   three	   times	   with	   1x	   TBS,	   then	   incubated	   with	   a	   1:4,000	   dilution	   of	   an	   anti-­‐His	  
alkaline	   phosphatase	   conjugated	   antibody	   (Abcam)	   in	   0.5%	  milk	   for	   one	   hour.	   	   The	   beads	  were	   then	  
washed	  three	  times	  with	  a	  high	  salt	  TBS,	  then	  incubated	  on	  the	  shaking	  arm	  for	  one	  hour	  with	  the	  high	  
salt	   buffer.	   	   They	  were	   then	  washed	   three	   times	  with	   BCIP	   buffer	   and	   developed	   as	   previously.	   	   Hit	  
beads	   turned	   purple	   and	   were	   removed	   and	   washed	   in	   NMP	   for	   four	   hours	   to	   decolorize,	   then	  
guanidine-­‐HCl	  to	  denature	  and	  remove	  and	  remaining	  protein.	  	  The	  beads	  were	  then	  washed	  ten	  times	  
with	  water	  and	  blocked	  in	  5%	  milk	  overnight.	  
Off-­‐Target	  Anti-­‐Screen	  (Supplemental	  Figure	  S16C):	  
	   The	  beads	   from	  the	   target	   screen	  were	  washed	   three	   times	  with	  1x	  TBS,	   then	   incubated	  with	  
the	   off-­‐target,	   wildtype	   PH	   Domain	   protein	   in	   0.5%	   milk	   for	   one	   hour	   on	   the	   shaking	   arm	   at	   room	  
temperature.	  	  The	  beads	  were	  washed	  three	  times	  with	  1x	  TBS,	  then	  incubated	  with	  a	  1:4,000	  dilution	  
of	  Anti-­‐His	  alkaline	  phosphatase	  conjugated	  antibody	   in	  0.5%	  milk	   for	  one	  hour	  at	   room	  temperature.	  	  
They	  were	  then	  washed	  three	  times	  with	  high	  salt	  buffer	  and	  let	  shake	  for	  one	  hour	  in	  high	  salt	  at	  room	  
temperature	  before	  being	  washed	  three	  times	  with	  BCIP	  buffer	  and	  developed	  as	  previously.	  	  The	  beads	  
that	  turned	  purple	  bind	  to	  both	  mutant	  and	  wildtype	  protein	  or	  to	  the	  anti-­‐his	  antibody	  and	  were	  set	  
aside.	  	  The	  beads	  that	  remained	  clear	  were	  picked	  and	  washed	  with	  guanidine-­‐HCl	  to	  remove	  any	  bound	  
proteins	  and	  blocked	  in	  5%	  milk	  overnight.	  
Product	  Screen	  (Supplemental	  Figure	  S16D):	  
	   The	  beads	  specific	  for	  the	  mutant	  PH	  domain	  were	  washed	  three	  times	  with	  1x	  TBS.	  	  They	  were	  
then	  incubated	  with	  a	  1:10,000	  dilution	  of	  streptavidin	  –	  alkaline	  phosphatase	  conjugate	  in	  0.5%	  milk	  for	  
one	  hour.	  	  The	  beads	  were	  washed	  three	  times	  with	  high	  salt	  TBS	  then	  let	  shake	  for	  one	  hour	  with	  high	  
salt	  buffer	  before	  being	  washed	  three	  times	  with	  BCIP	  buffer	  and	  developed	  as	  previously.	   	  The	  beads	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that	   turned	   purple	   contained	   the	   anchor	   peptide	   covalently	   bound	   to	   the	   bead	   and	   had	   formed	   a	  
protein-­‐catalyzed	  in	  situ	  click	  reaction.	  	  These	  beads	  were	  collected	  and	  stripped	  with	  guanidine-­‐HCl	  for	  
one	   hour,	   washed	   ten	   times	   with	   water,	   and	   sequenced	   via	   Edman	   degradation	   as	   per	   the	   anchor	  
candidate	  hits.	  	  There	  were	  22	  total	  hit	  beads	  (Table	  S4).	  	  Upon	  sequencing,	  the	  selected	  hits	  ended	  up	  
containing	  only	  four	  amino	  acids	  instead	  of	  five.	  	  One	  of	  the	  random	  amino	  acids	  must	  have	  not	  coupled	  
upon	  library	  synthesis,	  but	  the	  sequences	  were	  used	  anyways.	  
	  
Streptavidin-­‐Agarose	  Immunoprecipitation	  Assays	  to	  Test	  Biligand	  Candidates	  
	   Four	  biligand	  candidates	  were	  chosen	  based	  on	  their	  hydrophobicity	  and	  sequence	  homology	  using	  
principal	  component	  analysis	  (Supplemental	  Figure	  S17).	  	  Biligands	  were	  synthesized	  by	  coupling	  the	  2°	  
ligand	   onto	   Rink	   Amide	   Resin	   on	   the	   Titan	   peptide	   synthesizer.	   	   The	   amide	   group	   on	   the	   end	   of	   the	  
Lys(N3)	  was	  capped	  by	  shaking	  the	  resin	  with	  2mL	  acetic	  anhydride,	  2mL	  NMP	  and	  0.5mL	  DIEA	  for	  three	  
times	  10	  minutes	  each,	   then	  washed	  with	  NMP.	   	   	   FMOC-­‐Propargylglycine-­‐Otbu	   (Pra)	  was	  clicked	  onto	  
the	  Lys(N3)	  on	  the	  2°	  ligand	  by	  incubating	  2	  equivalents	  of	  the	  Pra	  amino	  acid	  with	  2	  equivalents	  CuI	  and	  
2	  equivalents	   ascorbic	   acid	  with	  1	  equivalent	   azide	  on	   resin	   in	  20%	  piperidine/NMP	   for	  3	  hours.	   	   The	  
resin	  was	  washed	  five	  times	  4mL	  with	  a	  chelating	  solution	  of	  1g	  sodium	  diethyldithiocarbamate	  in	  20mL	  
NMP	  and	  1mL	  DIEA.	   	   The	  anchor	  was	   then	  built	  onto	   the	  2°	   ligand	  on	  bead,	  and	  an	  N-­‐terminal	  PEG5-­‐
biotin	   tag	  was	   added.	   	   Assays	  were	   performed	   exactly	   as	   for	   the	   anchor	   ligands,	   except	   for	   two	   key	  
differences.	   	   The	   biligand	   assays	   were	   done	   with	   6ug	   of	   GST-­‐tagged	   PHD	   protein,	   instead	   of	   the	  
untagged	   PHD	   that	   was	   used	   in	   the	   anchor	   immunoprecipitations.	   	   The	   immunoprecipitation	   assays	  
were	  also	  conducted	  out	  of	  1%	  serum	  in	  1x	  TBS,	  as	  opposed	  to	  just	  1x	  TBS,	  and	  results	  can	  be	  seen	  in	  
Supplemental	  Figure	  S18.	  	  As	  can	  be	  seen	  from	  the	  western	  blot,	  all	  of	  the	  biligands	  improved	  upon	  the	  
anchor	  binding	  to	  the	  E17K	  PHD	  protein,	  but	  yleaf-­‐yksy	  showed	  the	  highest	  signal	  for	  the	  E17K	  protein	  
while	  still	  demonstrating	  the	  lowest	  off-­‐target	  signal	  to	  the	  WT	  protein.	  
	  
Screen	  for	  Triligand	  Peptide	  (Supplemental	  Figure	  S19)	  
	   The	  best	  biligand	  candidate	  as	  determined	  in	  immunoproecipitation	  assays	  –	  yleaf-­‐Tz-­‐yksy	  -­‐	  was	  
scaled	  up	  with	  a	  C-­‐terminal	  PEG5-­‐biotin	   for	  detection	  during	  the	  assay	  by	  coupling	  PEG5	  onto	  NovaTag	  
Biotin	  resin	  (EMD).	  	  Then	  Lys(N3)-­‐yksy	  was	  coupled	  onto	  the	  resin	  on	  the	  Titan	  peptide	  synthesizer,	  and	  
FMOC-­‐Pra-­‐Otbu	  was	  clicked	  on	  as	  above.	  	  The	  resin	  was	  then	  placed	  back	  on	  the	  Titan	  to	  synthesize	  the	  
remaining	  “Lys(N3)-­‐yleaf”	  portion	  –	  the	  Lys(N3)	  serving	  as	  the	  click	  handle	  for	  the	  triligand	  screen.	  	  The	  
biligand	  was	  then	  TFA	  cleaved	  from	  the	  resin	  and	  purified	  (Supplemental	  Figure	  S31).	  	  The	  screens	  were	  
completed	   using	   a	   random	   5	   D-­‐amino	   acid	   library	   with	   a	   C-­‐terminal	   D-­‐propargylglycine	   alkyne	   click	  
handle,	  and	  were	  otherwise	  performed	  exactly	  as	  for	  the	  biligand,	  including	  all	  concentrations.	  	  Only	  3	  
hit	  beads	  were	  discovered	   in	  this	  screen,	  and	  the	  first	  hit	  had	  a	  nonsensical	  sequence	  so	  could	  not	  be	  
used.	  	  See	  Table	  S5	  for	  hits.	   	  Both	  of	  the	  hits	  were	  scaled	  up	  and	  tested	  for	  binding	  using	  ELISA	  assays	  
(Supplemental	  Figure	  S20)	  using	  the	  protocol	  for	  the	  full	  ELISA	  curves	  for	  the	  ligands.	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Full	  ELISA	  curves	  for	  Ligands	  
	   The	  full	  curve	  ELISAs	  were	  obtained	  using	  streptavidin	  coated	  ELISA	  plates	  (Pierce).	  	  The	  ligands	  
–	   anchor,	   biligand,	   triligand	   and	   “eflya”	   scrambled	   anchor	   peptide	   blank	   -­‐	   were	   laid	   down	   at	   a	  
concentration	  of	  1μM	  for	  one	  hour.	  	  Two	  lanes	  of	  each	  ligand	  were	  used	  on	  the	  plate	  for	  both	  proteins	  –	  
WT	  and	  E17K	  GST-­‐PH	  Domain.	  The	  plates	  were	  blocked	  with	  5%	  BSA	  for	  two	  hours.	   	  Dilutions	  of	  both	  
WT	  and	  E17K	  GST-­‐PH	  Domain	  proteins	  were	  made	  in	  0.5%	  BSA	  in	  1xTBS	  starting	  from	  1μM	  –	  0.5nM	  by	  
serially	  diluting	  1:2	  down	  a	  series	  of	  8	  samples.	  	  For	  each	  ligand,	  a	  no	  protein	  blank	  was	  also	  used.	  	  The	  
proteins	  were	   incubated	  with	  the	  blocked	  plate	  for	  one	  hour,	  washed	  3x	  with	  1xTBST	  +	  0.5%	  BSA	  and	  
tapped	  dry,	  then	  detected	  with	  a	  1:10,000	  dilution	  of	  an	  HRP	  conjugated	  anti-­‐GST	  pAb.	  	  The	  plate	  was	  
again	  washed	  3x	  with	  1xTBST	  and	  tapped	  dry.	   	   It	  was	  developed	  with	  a	  1:1	  solution	  of	  TMB	  substrate	  
and	  development	  was	  stopped	  with	  1M	  H2SO4	  and	  read	  on	  a	  plate	  reader.	  	  The	  curves	  in	  Supplementary	  
Figure	  S21	  were	  plotted	  by	  normalizing	  the	  signal	  by	  the	  blank	  wells,	  and	  were	  fitted	  to	  a	  Hill	  function	  in	  
GraphPad	  using	  a	  common	  saturation	  and	  slope	  (Bmax	  =	  1.466	  +/-­‐	  0.03,	  h	  =	  0.7383	  +/-­‐	  0.025).	  
Fluorescence	  Polarization	  Assays	  
	   The	   yleaf	   anchor	   and	   triligand	   were	   synthesized	   with	   Cy3	   for	   fluorescence	   polarization	   (FP)	  
assays.	  	  The	  assays	  between	  the	  anchor	  ligand	  and	  the	  peptide	  epitopes	  were	  done	  by	  making	  a	  100	  μM	  
starting	  concentration	  of	  each	  WT	  and	  E17K	  mutant	  epitopes,	  and	  diluting	  it	  4x	  down	  a	  series	  of	  12	  wells	  
in	  a	  black	  96	  well	  polystyrene	  plate.	  	  Cy3-­‐anchor	  ligand	  was	  added	  to	  the	  wells	  for	  a	  final	  concentration	  
of	  200nM,	  and	  the	  plate	  was	  incubated	  for	  one	  hour	  at	  room	  temperature	  with	  shaking.	  	  The	  plate	  was	  
read	  on	  a	  Flexstation3	  fluorescent	  plate	  reader.	  
	   The	   full	   protein	   assays	  were	   completed	   by	  making	   a	   1μM	   starting	   protein	   concentration	   and	  
diluting	  2x	  down	  a	  series	  of	  12	  wells	  in	  a	  black	  96	  well	  polystyrene	  plate.	  	  Ligand	  (either	  Cy3-­‐anchor	  or	  
Cy3	  triligand)	  was	  added	  to	  the	  wells	  for	  a	  final	  concentration	  of	  133nM	  for	  the	  E17K	  protein	  and	  400nM	  
for	  the	  WT	  protein.	  	  The	  plate	  was	  incubated	  at	  room	  temperature	  for	  one	  hour	  with	  shaking,	  and	  read	  
on	  a	  Flexstation3	  plate	  reader.	  
	   The	   data	  were	   fitted	   by	   subtracting	   the	   average	   of	   the	   low	   concentration	   baseline	   to	   zero	   in	  
order	  to	  use	  the	  Hill	  fit.	  	  Using	  GraphPad	  Prism,	  the	  curves	  were	  fitted	  to	  a	  Hill	  function	  using	  a	  common	  
saturation	  point.	  
	   For	   all	   FP	   assays,	   the	   noise	   level	   is	   high	   when	   there	   is	   little	   binding	   –	   i.e.	   when	   the	   protein	  
concentration	   is	  very	   low,	   for	   the	  assays	  of	   the	   fluorescent	  yleaf	  anchor	   ligand	  with	  WT	  protein.	   	  This	  
likely	  arises	  from	  a	  small	  amount	  of	  PCC	  Agent	  adsorbed	  to	  the	  microwell	  surface.	  	   	  We	  thus	  validated	  
the	  yleaf-­‐WT	  protein	  binding	  assays	  via	  three	  independent	  measurements	  (Supplemental	  Figure	  S6).	  	  
	   The	  anchor-­‐epitope	  assay	  can	  be	  seen	  in	  Figure	  2d.	  	  The	  anchor-­‐full	  protein	  assay	  can	  be	  seen	  in	  
Figure	  2c,	  and	  the	  triligand-­‐full	  protein	  assay	  is	  Figure	  5c.	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Point	  ELISA	  assays	  for	  Triligand	  Binding	  to	  Akt1	  and	  Akt2	  Wildtype	  and	  E17K	  Mutant	  
	   These	  assays	  were	  conducted	  to	  test	  the	  binding	  of	  the	  triligand	  to	  the	  off-­‐target	  Akt2	  wildtype	  
and	   mutant	   proteins.	   	   For	   this	   assay,	   all	   samples	   were	   taken	   in	   triplicate	   for	   statistical	   purposes.	  	  
Triligand	  peptide	  was	  first	  immobilized	  onto	  Neutravidin	  ELISA	  plates	  (Pierce)	  for	  one	  hour.	  	  A	  scrambled	  
anchor	  peptide,	  eflya,	  was	  used	  as	  the	  no-­‐ligand	  blank,	  as	  the	  GST	  proteins	  has	  significant	  background	  
binding	  to	  a	  blank	  Neutravidin	  plate.	  	  The	  plates	  were	  then	  blocked	  with	  5%	  BSA	  overnight.	  	  Protein	  was	  
laid	  down	  at	  a	  concentration	  of	  100nM	  for	  samples	  wells	  and	  the	  blank,	  scrambled	  peptide	  wells.	  	  GST	  
protein	  alone	   (Abcam)	  was	  also	   incubated	  with	   the	   triligand	  and	  scrambled	  peptide	  as	  a	  control.	   	  The	  
proteins	  were	   incubated	   for	   one	   hour,	   then	  washed	   three	   times	  with	   1xTBST.	   	   The	   protein	  was	   then	  
detected	  with	  1:10,000	  anti-­‐GST	  mouse	  mAb	  (Fisher,	  #MA4-­‐004)	  for	  one	  hour,	  washed	  three	  times	  with	  
1xTBST	  and	  developed	  with	  a	  1:1	  mixture	  of	  TMB	  substrate	  for	  ten	  minutes.	  	  The	  samples	  were	  plotted	  
by	   subtracting	   the	   blanks	   and	   averaging	   the	   sample	   wells.	   	   The	   highest	   signal	   was	   considered	   100%	  
binding,	  and	  the	  other	  samples	  were	  normalized	  accordingly.	  The	  homology	  of	  the	  PH	  Domain	  between	  
Akt1E17K	  and	  Akt2E17K	  is	  79%	  as	  calculated	  by	  a	  pairwise	  sequence	  analysis	  using	  Blast2Seq	  between	  the	  
Akt1	   E17K	   structure	   (2UZR)	   and	   the	   Akt2	   PHD	   structure	   (1P6S).	   	   This	   assay	   can	   be	   seen	   in	  
Supplementary	  Figure	  S22.	  
	  
Point	  ELISAs	  for	  Anchor	  and	  Triligand	  Binding	  in	  Human	  Serum	  
	   These	   assays	   were	   conducted	   to	   test	   the	   off-­‐target	   interactions	   of	   the	   anchor	   and	   triligand.	  	  
These	   point	   ELISAs	   were	   conducted	   in	   1%	   and	   2%	   human	   serum	   to	   determine	   if	   the	   binding	   of	   the	  
protein	  to	  its	  desired	  target	  is	  lessened	  by	  the	  presence	  of	  high	  amounts	  of	  other	  human	  proteins.	  	  For	  
this	  assay,	  Anchor	  and	  Triligand	  peptide	  were	  first	  immobilized	  onto	  Neutravidin	  ELISA	  plates	  (Pierce)	  for	  
one	  hour.	  	  A	  scrambled	  anchor	  peptide,	  eflya,	  was	  used	  as	  the	  no-­‐ligand	  blank,	  as	  the	  GST	  proteins	  has	  
significant	  background	  binding	  to	  a	  blank	  Neutravidin	  plate.	  	  The	  plates	  were	  then	  blocked	  with	  5%	  BSA	  
overnight.	   	   Protein	   was	   laid	   down	   at	   a	   concentration	   of	   150nM	   for	   samples	   wells	   and	   the	   blank,	  
scrambled	   peptide	   wells	   in	   either	   0%,	   1%	   or	   2%	   human	   serum	   in	   TBS	   buffer.	   	   The	   proteins	   were	  
incubated	   for	   one	   hour,	   then	  washed	   three	   times	  with	   1xTBST.	   	   The	   protein	  was	   then	   detected	  with	  
1:10,000	  anti-­‐GST	  mouse	  mAb	   (Fisher,	  #MA4-­‐004)	   for	  one	  hour,	  washed	   three	   times	  with	  1xTBST	  and	  
developed	   with	   a	   1:1	   mixture	   of	   TMB	   substrate	   for	   ten	   minutes.	   	   The	   samples	   were	   plotted	   by	  
subtracting	   the	   blanks	   (elfya	   scrambled	   peptide	   binding	   to	   protein).	   	   This	   assay	   can	   be	   seen	   in	  
Supplemental	  Figure	  S23.	  
	  
PIP3	  Agarose	  Immunoprecipitation	  Inhibition	  Assays	  
	   PIP3	  Agarose	  beads	  (Echelon)	  were	  used	  to	  detect	  for	  the	  inhibition	  of	  PH	  Domain	  binding	  to	  its	  
substrate,	   PIP3,	   upon	   incubation	  with	   the	   anchor	   candidate	   peptide	   ligands.	   	   To	   test	   the	   inhibition	   of	  
each	  of	  the	  ligands,	  anchor,	  biligand	  and	  triligand,	  20μL	  of	  resin	  slurry	  was	  added	  to	  each	  of	  four	  tubes	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and	  washed	  three	  times	  with	  1x	  TBS.	  	  Protein,	  2μg	  (234nM)	  of	  E17K	  mutant,	  was	  pre-­‐incubated	  for	  one	  
hour	  at	  room	  temperature	  with	  either	  DMSO	  (no	  protein	  blank),	  anchor,	  biligand	  or	  triligand	  at	  2.38μM	  
(10x	  in	  relation	  to	  protein)	  in	  200μL	  of	  1x	  TBS.	  	  For	  the	  control,	  mutant	  PH	  Domain	  was	  incubated	  with	  
1x	  TBS	  and	  1μL	  MSO	  to	  mimic	   the	   ligand	  conditions.	   	  These	  protein	  samples	  were	   then	  added	  to	  PIP3	  
agarose	  in	  a	  Spin-­‐X	  tube	  and	  incubated	  at	  room	  temperature	  for	  two	  hours.	  	  The	  resin	  was	  washed	  three	  
times	  with	  1x	  TBS	  with	  0.25%	  IGEPAL	  CA-­‐630,	  spun	  out	  to	  dry	  completely,	  then	  denatured	  with	  50μL	  3x	  
SDS	  gel	  loading	  buffer	  for	  10	  min	  at	  95°C.	  	  The	  gel	  loading	  buffer	  was	  spun	  out	  of	  the	  resin	  and	  detected	  
via	  western	  blot	  as	  per	  the	  streptavidin	  -­‐	  agarose	  immunoprecipitation	  assays.	  	  Inhibition	  was	  indicated	  
by	  a	  decrease	  in	  the	  amount	  of	  PH	  Domain	  that	  was	  pulled	  from	  solution	  by	  the	  resin.	  	  See	  Figure	  5d.	  
	   Expanded	   inhibition	  blots	  with	  either	  WT	  of	  E17K	  mutant	  protein	  were	  performed	   in	  a	   similar	  
fashion.	   	   Twelve	   tubes	  of	   20μL	  of	   PIP3	   agarose	  were	  washed	   three	   times	  with	   1x	   TBS.	   	   2μg	  of	   either	  
wildtype	  or	  mutant	  PH	  Domain-­‐GFP	  protein	  (234nM)	  in	  200uL	  1xTBS	  were	  pre-­‐incubated	  for	  30	  minutes	  
with	   differing	   concentrations	   of	   triligand:	   0.1eq	   (23.4nM),	   1eq	   (234nM),	   10eq	   (2.34μM),	   100eq	  
(23.4μM),	  and	  1000eq	  (234μM).	  	  The	  protein	  and	  triligand	  solutions	  were	  then	  incubated	  with	  the	  PIP3	  
resin	   for	   2	   hours	   at	   room	   temperature.	   	   The	   resins	   were	   washed,	   eluted,	   and	   blotted	   as	   per	   all	   PH	  
Domain	  western	  blots.	  	  See	  Figure	  5e.	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Figure	  S1:	  CD	  Spectra	  of	  33mer	  fragment,	  folded	  and	  denatured	  	  	  
The	  blue	   spectra	   indicated	   the	  33mer	   target	   fragment	   that	  was	  used	   in	   screening.	   	   The	  dip	  at	  217nm	  
indicates	  β-­‐sheet	   formation,	  as	   to	  be	  expected	   from	  the	  protein	  structure.	   	  The	  CD	  was	  also	  collected	  
under	  denaturing	  conditions	  to	  ensure	  that	  the	  peak	  at	  217nm	  was	  due	  to	  peptide	  structure.	  	  The	  messy	  
spectra	  from	  200-­‐210nm	  are	  probably	  due	  to	  the	  biotin	  tags	  attached	  to	  the	  fragment.	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Figure	  S2:	  Screening	  Strategy	  for	  Anchor	  Ligand	  Determination	  
	  (a)	  Preclear:	  Library	  beads	  are	  incubated	  with	  streptavidin	  -­‐	  alkaline	  phosphatase	  conjugate	  to	  remove	  
any	   library	   beads	   that	   bind	   to	   this	   or	   the	   BCIP	   reagents.	   (b)	   Screen:	   Precleared	   library	   beads	   are	  
incubated	   with	   the	   33-­‐mer	   target	   peptide	   containing	   an	   azide	   in	   situ	   click	   handle.	   	   The	   fragment	  
catalyzes	   triazole	   formation	   between	   the	   alkyne	   on	   the	   33-­‐mer	   target	   and	   the	   azide	   on	   beads	   that	  
contain	  peptide	  sequences	  that	  bind	  specifically	  to	  the	  33-­‐mer	  in	  a	  close	  enough	  proximity	  to	  the	  alkyne	  
substitution	   for	  a	  click	   reaction	  to	  occur	  without	  copper.	   	  The	  unclicked	  peptide	   is	   then	  stripped	   from	  
the	   beads	   and	   the	   remaining	   covalently	   attached	   33-­‐mer	   is	   detected	   by	   streptavidin	   –	   alkaline	  
phosphatase	  with	  BCIP	  development.	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Figure	  S3:	  Unsupervised	  Clustering	  of	  Anchor	  Sequence	  Ligands	  by	  AA	  Similarity	  
Hit	  sequences	  from	  the	  anchor	  screen	  were	  analyzed	  by	  their	  hydrophobicity	  and	  sequence	  homology	  
using	  principal	  component	  analysis.	  	  Circled	  clusters	  indicate	  regions	  where	  a	  peptide	  was	  selected	  and	  
scaled-­‐up	  as	  a	  possible	  anchor	  sequence.	  	  The	  potential	  anchor	  sequences	  that	  were	  tested	  are:	  dqntr,	  
ypwve,	  eefef,	  yleaf	  and	  elnhy.	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Figure	  S4	  Streptavidin-­‐Agarose	  Immunoprecipitation	  Assays	  for	  Anchor	  Ligand	  
Binding	  Affinity	  Streptavidin-­‐agarose	  was	  incubated	  with	  a	  panel	  of	  potential	  anchor	  
sequences	  that	  were	  synthesized	  with	  biotin	  tags.	  	  These	  resins	  were	  then	  incubated	  
with	  either	  wildtype	  or	  E17K	  Mutant	  PHD	  to	  measure	  the	  amount	  of	  
immunoprecipitation	  for	  each	  potential	  anchor	  ligand.	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Figure	  S5:	  HPLC-­‐detected	  Immunoprecipitation	  Assays	  for	  Epitope	  Targeting	  Verification	  	  The	  major	  
peak	  indicated	  by	  “33-­‐mer”	  demonstrates	  the	  amount	  of	  33-­‐mer	  fragment	  that	  was	  pulled	  down	  by	  
either	  the	  “yleaf”	  anchor	  ligand	  or	  an	  off-­‐target	  ligand	  “eefef”,	  both	  of	  which	  can	  be	  seen	  in	  the	  HPLC	  
due	  to	  the	  Guanadine	  elution	  stripping	  them	  from	  the	  resin	  with	  the	  fragment.	  	  The	  amount	  of	  33-­‐mer	  






―	  yleaf,	  E17K	  33mer	  
― eefef,	  E17K	  33mer	  
― yleaf,	  WT	  33mer 
― blank,	  E17K	  33mer 
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Figure	  S6:	  Demonstration	  of	  Consistency	  in	  Baseline	  for	  WT	  Fluorescence	  Polarization	  Anisotropy	  Raw	  
Data	  





Figure	  S7:	  Protein	  stain	  and	  labeling	  blot	  	  
This	  represents	  a	  labeling	  experiment	  performed	  on	  GST-­‐PHD	  protein	  using	  the	  anchor	  ligand	  with	  a	  
labeling	  arm	  that	  transfers	  a	  biotin	  onto	  the	  target	  protein.	  	  The	  anchor	  ligand	  was	  incubated	  with	  1uM	  
of	  protein	  at	  the	  concentrations	  shown	  above.	  	  The	  blank	  includes	  no	  labeling	  arm.	  	  The	  protein	  stain	  is	  
a	  Ponceau	  stain,	  and	  the	  western	  blot	  for	  biotinylation	  was	  performed	  using	  an	  anti-­‐biotin-­‐HRP	  
antibody.	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Figure	  S8:	  MALDI	  -­‐TOF	  of	  Cy5	  unlabeled	  trypsin	  digests	  from	  tosyl	  labeling	  experiments	  	  	  
The	  unlabeled	  GST-­‐E17K	  PHD-­‐	  Akt1	  protein	  was	  trypsin	  digested	  and	  the	  fragments	  were	  analyzed	  by	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Figure	  S9:	  MALDI	  -­‐TOF	  of	  Cy5	  dye-­‐labeled	  trypsin	  digests	  from	  tosyl	  labeling	  experiments.	  	  	  
The	  GST-­‐E17K	  PHD-­‐	  Akt1	  protein	  that	  had	  been	  labeled	  by	  the	  anchor	  –	  tosyl	  –	  Cy5	  was	  trypsin	  digested	  
and	  the	  fragments	  were	  analyzed	  by	  MALDI-­‐TOF	  MS.	  	  These	  fragments	  were	  compared	  to	  those	  seen	  in	  
Figure	  S8	  to	  determine	  which	  ones	  contained	  the	  addition	  of	  the	  dye	  molecule.	  	  Those	  fragments	  were	  
further	  analyzed	  by	  MALDI-­‐TOF/TOF	  MS.	  See	  Table	  S3	  and	  detailed	  methods	  description	  for	  the	  data	  
comparison	  and	  workup.	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Figure	  S10:	  MALDI-­‐TOF/TOF	  Cy5	  dye-­‐labeled	  YFLLK	  fragmentation	  
The	  YFLLK	  –	  Cy5	  Labeled	  trypsin	  fragment	  analyzed	  by	  MALDI-­‐TOF/TOF	  MS.	  	  The	  fragments	  shown	  above	  
demonstrate	  that	  the	  Cy5-­‐dye	  is	  on	  the	  Y	  amino	  acid,	  which	  corresponds	  to	  the	  results	  found	  by	  authors	  
of	  the	  original	  technique4.	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Figure	  S11:	  MALDI-­‐TOF/TOF	  unlabeled	  YFLLK	  fragmentation	  
	   	  
	  
The	  unlabeled	  YFLLK	  trypsin	  fragment	  analyzed	  by	  MALDI-­‐TOF/TOF	  MS.	  	  The	  fragments	  shown	  
demonstrate	  that	  we	  are	  able	  to	  use	  MALDI-­‐TOF/TOF	  to	  readily	  fragment	  the	  trypsin-­‐digested	  proteins	  
in	  order	  to	  determine	  the	  location	  of	  the	  dye	  label.	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Figure	  S12:	  Sequence	  of	  PH	  Domain	  with	  Trypsin	  Digests	  and	  Labeled	  Fragments	  
The	  sequence	  of	  the	  PH	  Domain	  is	  digested	  by	  trypsin	  at	  the	  dashed	  lines.	  	  The	  fragments	  that	  were	  
seen	  to	  contain	  a	  label	  are	  highlighted	  in	  red	  and	  the	  sites	  that	  may	  contain	  a	  label	  are	  highlighted	  in	  
cyan.	  	  Note	  that	  the	  first	  fragment	  has	  two	  possible	  labeling	  sites,	  and	  the	  peaks	  for	  both	  the	  singly	  and	  
doubly	  labeled	  MALDI	  fragments	  were	  seen.	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Figure	  S13:	  Comparison	  of	  Retention	  of	  CPP-­‐Anchor-­‐Cy5	  with	  and	  without	  washing	  step	  
The	  top	  two	  figures	  are	  of	  the	  CPP-­‐anchor-­‐cy5	  in	  cells	  with	  no	  wash	  step.	  	  The	  bottom	  two	  images	  show	  
the	  relative	  retention	  after	  the	  addition	  of	  a	  one	  hour	  wash	  step	  to	  reduce	  the	  amount	  of	  unbound	  CPP	  
retained	  by	  the	  cells.	  	  Using	  ImageJ,	  the	  mean	  intensity	  of	  Cy5	  was	  calculated	  on	  a	  per	  cell	  basis,	  and	  
those	  numbers	  are	  given	  in	  the	  table	  below	  the	  image.	  	  Difference	  between	  the	  per	  cell	  fluorescence	  in	  
E17K	  and	  wildtype	  transfected	  cells	  were	  not	  significant	  without	  washing,	  and	  significant	  (p	  =	  0.00018)	  
with	  washing.	  	  While	  the	  wash	  step	  likely	  will	  not	  remove	  all	  of	  the	  excess	  or	  unbound	  peptide,	  its	  
inclusion	  allows	  for	  a	  difference	  in	  intracellular	  sequestration	  to	  be	  detected	  between	  the	  cell	  types.	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Figure	  S14:	  Control	  Experiment:	  	  In	  cell	  Imaging	  of	  HEK293T	  cells	  with	  no	  
GFP-­‐PH	  Domain	  expressed	  
This	  control	  was	  designed	  to	  prove	  that	  the	  ligand	  binding	  is	  due	  to	  the	  
presence	  of	  the	  expressed	  E17K	  GFP-­‐PH	  Domain	  in	  the	  cells.	  	  These	  cells	  were	  
not	  transfected	  to	  express	  the	  GFP	  PH	  Domain	  protein	  and	  were	  still	  treated	  
with	  50nM	  concentration	  of	  yleaf	  –	  PEG5	  –	  TAT	  –	  Cy5.	  	  As	  in	  the	  non-­‐control	  
assays,	  live	  cells	  were	  treated	  with	  the	  labeled	  PCC	  Agent,	  fixed,	  washed,	  and	  
then	  identically	  imaged.	  	  Following	  those	  protocols,	  neither	  GFP	  fluorescence	  
signal	  nor	  Cy5	  fluorescence	  was	  observed	  within	  the	  cells.	  	  If	  the	  ligand	  were	  
sequestered	  in	  cells	  for	  reasons	  other	  than	  binding	  to	  the	  GFP-­‐PH	  Domain,	  we	  
would	  expect	  to	  see	  Cy5	  signal	  in	  these	  cells.	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Figure	  S15:	  	  Control	  Experiment:	  	  In	  cell	  imaging	  PEG5	  –	  TAT	  –	  Cy5	  control.	  	  
Cells	  expressing	  GFP-­‐	  E17K	  mutant	  protein	  were	  incubated	  with	  50nM	  PEG5	  –	  
TAT	  –	  Cy5	  (the	  yleaf	  ligand	  is	  missing).	  	  This	  control	  exposes	  the	  cells	  to	  all	  of	  the	  
components	  of	  the	  imaging	  agent	  except	  for	  the	  anchor	  ligand	  peptide.	  	  As	  in	  
the	  non-­‐control	  assays,	  live	  cells	  were	  treated	  with	  the	  fluorescent	  reagent,	  
fixed,	  washed,	  and	  then	  identically	  imaged.	  	  Very	  little	  Cy5	  fluorescence	  signal	  is	  
observed,	  consistent	  with	  the	  observation	  that	  the	  fluorescent	  signal	  in	  the	  
non-­‐control	  assays	  arises	  from	  the	  GFP-­‐E17K	  mutant	  PH	  Domain	  interacting	  
with	  the	  yleaf	  containing	  PCC	  Agent.	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Figure	  S16:	  Screening	  Strategy	  for	  Biligand	  Determination	  
(a)	  Preclear:	  Library	  beads	  are	  incubated	  with	  streptavidin	  -­‐	  alkaline	  phosphatase	  conjugate	  to	  remove	  
any	  library	  beads	  that	  bind	  to	  this	  or	  the	  BCIP	  reagents.	  (b)	  Target	  Screen:	  Precleared	  beads	  are	  
incubated	  with	  the	  target	  and	  anchor	  ligand	  and	  allowed	  to	  “click”	  to	  form	  a	  triazole.	  	  The	  presence	  of	  
the	  target	  his-­‐tagged	  PH	  Domain	  is	  detected	  via	  an	  anti-­‐His	  alkaline	  phosphatase	  antibody.	  	  The	  hit	  
beads	  are	  then	  collected,	  decolorized,	  and	  stripped	  of	  protein.	  (c)	  Anti-­‐Screen:	  Hit	  beads	  from	  the	  target	  
screen	  are	  incubated	  with	  the	  off-­‐target	  PH	  Domain	  and	  anti-­‐his	  alkaline	  phosphatase.	  	  These	  hit	  beads	  
bind	  to	  both	  the	  target	  and	  off-­‐target	  (WT	  and	  E17K	  mutant).	  (d)	  Product	  Screen:	  The	  remaining	  beads	  
are	  probed	  with	  streptavidin-­‐alkaline	  phosphatase	  to	  determine	  which	  contain	  the	  click	  product	  and,	  
thereby,	  have	  shown	  biligand	  formation.	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Figure	  S17:	  Unsupervised	  Clustering	  of	  Biligand	  Sequence	  Ligands	  by	  AA	  Similarity	  
Hit	  sequences	  from	  the	  biligand	  screen	  were	  analyzed	  by	  their	  hydrophobicity	  and	  sequence	  homology	  
using	  principal	  component	  analysis.	  	  Clusters	  circled	  in	  green	  indicate	  clustered	  regions	  and	  the	  cyan	  
circles	  indicate	  the	  peptide	  that	  was	  selected	  and	  scaled-­‐up	  as	  a	  possible	  biligand	  sequence.	  	  The	  
potential	  biligand	  sequences	  that	  were	  tested	  are:	  yleaf-­‐ywrl,	  yleaf-­‐yksy,	  yleaf-­‐rdyr,	  and	  yleaf-­‐hyrw,	  
where	  “yleaf”	  is	  the	  anchor	  ligand	  and	  the	  “-­‐“	  indicates	  the	  location	  of	  the	  triazole	  linkage.	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Figure	  S18:	  Immunoprecipitaiton	  Assay	  Results	  for	  Biligand	  Candidates	  




Lane	  1:	  protein	  positive	  blot	  control;	  lane	  2:	  WT	  GST-­‐PHD,	  no	  ligand;	  lane	  3:	  WT	  GST-­‐PHD,	  yleaf	  anchor;	  
lane	  4:	  WT	  GST-­‐PHD	  yleaf-­‐hryw	  biligand;	  lane	  5:	  WT	  GST-­‐PHD,	  yleaf-­‐rdyr	  biligand;	  lane	  6:	  WT	  GST-­‐PHD,	  
yleaf-­‐yksy	  biligand;	  lane	  7:	  WT	  GST-­‐PHD,	  yleaf-­‐ywrl	  biligand.	  	  Lanes	  8-­‐13	  are	  the	  same	  as	  2-­‐7,	  but	  with	  
the	  E17K	  GST-­‐PHD	  protein.	  	  Note	  that	  all	  of	  the	  biligand	  candidates	  improve	  upon	  the	  binding	  of	  the	  
anchor	  ligand,	  but	  yleaf-­‐yksy	  shows	  the	  greatest	  signal	  in	  binding	  the	  E17K	  protein	  and	  the	  lowest	  in	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Figure	  S19:	  Screening	  Strategy	  for	  Triligand	  Determination	  
(a)	  Preclear:	  Library	  beads	  are	  incubated	  with	  streptavidin	  -­‐	  alkaline	  phosphatase	  conjugate	  to	  remove	  
any	   library	   beads	   that	   bind	   to	   this	   or	   the	   BCIP	   reagents.	   (b)	   Target	   Screen:	   Precleared	   beads	   are	  
incubated	  with	   the	   target	  and	  biligand	  and	  allowed	   to	  “click”	   to	   form	  a	   triazole.	   	  The	  presence	  of	   the	  
target	  his-­‐tagged	  PH	  Domain	   is	  detected	  via	  an	  anti-­‐His	  alkaline	  phosphatase	  antibody.	   	  The	  hit	  beads	  
are	   then	   collected,	   decolorized,	   and	   stripped	   of	   protein.	   (c)	   Anti-­‐Screen:	   Hit	   beads	   from	   the	   target	  
screen	  are	   incubated	  with	   the	  off-­‐target,	  WT	  PH	  Domain	  and	  anti-­‐his	  alkaline	  phosphatase.	   	  These	  hit	  
beads	  bind	  to	  both	  the	  target	  and	  off-­‐target	  (WT	  and	  E17K	  mutant).	  (d)	  Product	  Screen:	  The	  remaining	  
beads	  are	  probed	  with	  streptavidin-­‐alkaline	  phosphatase	  to	  determine	  which	  contain	  the	  click	  product	  
and,	  thereby,	  have	  shown	  triligand	  formation.	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Figure	  S20:	  ELISA	  assay	  of	  two	  triligand	  candidates	  
	   	  
	  
This	  sandwich	  ELISA	  was	  performed	  with	  biotinylated	  triligands	  immobilized	  on	  a	  neutravidin	  plate.	  	  The	  
protein	   was	   incubated	   in	   varying	   concentrations	   and	   detected	   with	   an	   anti-­‐GST	   antibody.	   	   The	   iryrn	  
triligand	  candidate,	  while	  demonstrating	  a	  higher	  affinity	  for	  the	  E17K	  protein	  than	  the	  ivdae	  candidate,	  
was	   not	   chosen	   due	   to	   an	   increased	   binding	   to	   the	   off-­‐target,	  WT	   protein.	   	   The	   triligand	   ivdae	   was	  
carried	  forward	  as	  the	  final	  triligand	  PCC	  agent.	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Figure	  S21:	  Full	  Sandwich	  ELISA	  curves	  of	  anchor,	  biligand	  and	  triligand	  against	  WT	  and	  E17K	  PH	  
Domain	  
ELISA	  assays	  were	  performed	  by	  immobilizing	  biotinylated	  ligand	  onto	  a	  neutravidin	  coated	  ELISA	  plate.	  	  
The	   plates	  were	   blocked	  with	   BSA,	   incubated	  with	   varying	   concentrations	   of	   GST-­‐tagged	   protein	   and	  
detected	  with	  an	  anti-­‐GST	  HRP	  antibody.	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Figure	  S22:	  Point	  ELISA	  demonstrating	  binding	  to	  both	  Akt1E17K	  and	  Akt2
E17K	  isoforms	  
ELISA	  assay	  was	  done	  as	  per	  the	  full	  curves,	  except	  only	  points	  were	  done	  at	  100nM	  concentration	  of	  
protein.	  	  The	  isoforms	  are	  79%	  homologous	  as	  calculated	  by	  a	  pairwise	  sequence	  analysis	  using	  
Blast2Seq	  between	  the	  Akt1	  E17K	  structure	  (2UZR)	  and	  the	  Akt2	  PHD	  structure	  (1P6S).	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Figure	  S23:	  Performance	  of	  Anchor	  and	  Triligand	  in	  1%	  and	  2%	  serum	  
The	  anchor	  and	  triligand	  were	  tested	  in	  a	  point	  ELISA	  against	  150nM	  of	  WT	  or	  E17K	  GST-­‐Akt1	  protein	  
spiked	  into	  0%,	  1%	  or	  2%	  human	  serum	  (HS)	  in	  TBS	  buffer.	  	  This	  assay	  uses	  the	  same	  format	  as	  the	  full-­‐
curve	  ELISAs	  in	  Supplemental	  Figure	  S21,	  and	  the	  ligand	  binding	  and	  specificity	  are	  consistent	  with	  what	  
was	  seen	  in	  that	  figure.	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Figure	  S24:	  MALDI-­‐TOF	  of	  33-­‐mer	  target	  fragment.	  	  
Sequence:	  Biotin-­‐	  MSDVAIVKEGWLKKRGKY[Pra]KTWRPRYFLLKNDG.	  	  Expected	  m/z:	  4214.9,	  observed	  
M+H:	  4215.93	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Figure	  S25:	  HPLC	  trace	  demonstrating	  purity	  of	  33-­‐mer	  E17K	  Fragment	  
The	  33-­‐mer	  fragment	  dissolved	  in	  buffer	  was	  run	  on	  an	  analytical	  HPLC	  to	  demonstrate	  the	  purity	  of	  the	  
peptide	  that	  was	  analyzed	  by	  MALDI	  in	  Figure	  S1.	  	  The	  peak	  below	  5	  minutes	  is	  the	  salt	  from	  the	  buffer.	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Figure	  S26:	  Structure	  and	  MALDI-­‐TOF	  of	  Biotin	  –	  PEG6	  –	  yleaf	  –	  Pra	  anchor	  ligand	  
	  
	  
The	  anchor	  ligand	  is	  appended	  with	  a	  PEG6-­‐biotin	  and	  a	  C-­‐terminal	  propargylglycine	  alkyne	  amino	  acid	  
for	  the	  click	  reaction	  during	  the	  screen.	  	  Expected	  M+Na:	  1319.62,	  observed:	  1319.89.	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Figure	  S27:	  MALDI-­‐TOF	  of	  6His	  –	  PEG5	  –	  Mut	  33mer	  Fragment	  
Sequence:	  HHHHHH	  –	  PEG5-­‐	  MSDVAIVKEGWLKKRGKY[Pra]KTWRPRYFLLKNDG.	  Expected:	  5160.72,	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Figure	  S28:	  MALDI-­‐TOF	  of	  6His	  –	  PEG5	  –	  WT	  33mer	  Fragment	  
Sequence:	  HHHHHH	  –	  PEG5-­‐	  MSDVAIVKEGWLKKRGKY[Pra]KTWRPRYFLLKNDG.	  Expected:	  5161.72,	  
observed:	  5162.78.	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Figure	  S29:	  MALDI-­‐TOF	  of	  CPP	  –	  yleaf	  –	  piperidine	  –	  tosyl	  –	  EG	  –	  Cy5	  for	  labeling	  studies	  
The	  anchor	  is	  built	  onto	  a	  TAT	  peptide,	  then	  appended	  with	  the	  piperidine	  linker	  and	  tosyl	  labeling	  arm	  
with	  a	  Cy5,	  as	  described	  above.	  	  Note,	  the	  Cy5	  anchor	  flies	  very	  poorly	  on	  the	  MALDI	  and	  so	  background	  
and	  slight	  impurities	  appear	  amplified.	  	  Expected:	  3319,	  observed:	  3319.6.	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Figure	  S30:	  Structure	  and	  MALDI-­‐TOF	  of	  yleaf	  –	  PEG5	  –	  TAT	  –	  Cy5	  for	  imaging	  studies	  
The	  anchor	  ligand	  is	  appended	  with	  a	  PEG5-­‐TAT,	  to	  ensure	  cell	  penetration,	  then	  a	  Cy5	  dye	  is	  added	  for	  
visualization.	  	  Expected:	  2937.72,	  observed:	  2937.83.	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Figure	  S31:	  MALDI	  of	  Lys(N3)	  –	  yleaf	  –	  yksy	  –	  PEG5	  –	  Biotin	  Biligand	  
	   	  
	  
The	  biligand	  is	  appended	  with	  a	  C-­‐terminal	  PEG5-­‐Biotin	  for	  detection	  in	  the	  screen	  and	  an	  N-­‐terminal	  
Lys(N3)	  for	  use	  in	  the	  in	  situ	  click	  screen.	  	  Expected:	  2248.1,	  observed:	  2249.1.	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Figure	  S32:	  Structure	  and	  MALDI-­‐TOF	  of	  Biotin	  –	  PEG5	  –	  ivdae	  –	  yleaf	  –	  yksy	  Triligand	  
	  
	   	  
	  
The	  triligand	  was	  appended	  with	  a	  biotin	  tag	  for	  detection.	  	  Expected:	  2888.39,	  Observed:	  2888.68	  
(M+H),	  2910.62	  (M+Na).	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Figure	  S33:	  Structure	  and	  MALDI-­‐TOF	  of	  Cy3-­‐PEG5-­‐yleaf	  for	  fluorescence	  polarization	  
The	  yleaf	  anchor	  was	  appended	  with	  an	  N-­‐terminal	  PEG5	  and	  a	  Cy3	  dye.	  	  Expected:	  1371.75,	  Observed:	  
1371.25.	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Figure	  S34:	  Structure	  and	  MALDI-­‐TOF	  of	  Cy3-­‐PEG5-­‐ivdae-­‐yleaf-­‐yksy	  triligand	  for	  fluorescence	  
polarization	  
The	  triligand	  was	  synthesized	  as	  usual	  and	  was	  appended	  with	  an	  N-­‐terminal	  PEG5	  and	  Cy3.	  Expected:	  
3057.56,	  observed:	  3057.32.	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Table	  S1:	  Hit	  sequences	  from	  Anchor	  Screen	  Against	  33-­‐mer	  Epitope	  (5hr)	  
Note	  that	  the	  missing	  or	  unclear	  sequences	  are	  due	  to	  an	  error	  in	  the	  ProciseCLC	  Edman	  degredation	  
machine	  and	  not	  the	  library	  itself.	  	  Therefore,	  they	  are	  counted	  in	  the	  statistic,	  but	  are	  not	  used	  due	  to	  
the	  uncertainty	  in	  the	  sequence.	  
Az2	   G	   v	   e	   k	   f	  
Az8	   y	   h	   e	   w	   f	  
Az4	   i	   s	   e	   y	   e	  
Az2	   p	   h	   w	   l/k	   f	  
Az8	   d	   l	   l	   t	   f	  
Az4	   a	   r	   s	   d	   f	  
Az8	   f	   k/l	   	   G	   t	  
Az8	   f	   e	   i	   q	   	  
Az8	   e	   e	   p	   d/n	   f	  
	  
Table	  S2:	  Hit	  Sequences	  from	  Anchor	  Screen	  Against	  33-­‐mer	  Fragment	  (overnight)	  
Az4	   e	   e	   f	   e	   f	  
Az8	   f	   e	   e	   a	   i	  
Az2	   e	   l	   n	   h	   y	  
Az2	   h	   a	   r	   h	   q	  
Az2	   h	   e	   w	   v	   t	  
Az4	   n	   w	   y	   a	   w	  
Az4	   n	   l	   v	   p	   n	  
Az2	   	   r	   r	   r	   f	  
Az4	   a	   l	   n	   s	   k	  
Az8	   p	   	   a	   y	   h	  
Az2	   n	   r	   y	   v	   r	  
Az8	   y	   l	   e	   a	   f	  
	  
	   	  
© 2015 Macmillan Publishers Limited. All rights reserved
NATURE CHEMISTRY | www.nature.com/naturechemistry 52
SUPPLEMENTARY INFORMATIONDOI: 10.1038/NCHEM.2223
S52	  






Expected	   Digest	  
Peak	  




1053.15	   500.78	  
	  
1051.6349	   499.265	   4296.69	   1.5151	  
	   	  1090.15	   537.78	  
	  
1114.6007	   562.2307	   5813.86	   24.4507	  
	   	  1118.11	   565.74	  
	  
1114.6007	   562.2307	   12649.91	   3.5093	  
	   	  1142.16	   589.79	  
	  
1132.6993	   580.329	   4217.63	   9.4607	  
	   	  1179.14	   626.77	  
	  
1173.6565	   621.287	   4393.2	   5.4835	  
	   	  1194.14	   641.77	  
	  
1201.732	   649.362	   5139.51	   7.592	  
	   	  1202.16	   649.79	  
	  
1201.732	   649.362	   4103.69	   0.428	  
	   	  1234.66	   682.29	   *	   1234.7826	   682.4126	   8193.47	   0.1226	  
	  
YFLLK	  
1300.08	   747.71	  
	  
1303.7273	   751.3573	   6445.8	   3.6473	  
	   	  1302.09	   749.72	  
	  
1303.7273	   751.357	   4496.81	   1.6373	  
	   	  1308.09	   755.72	  
	  
1303.7525	   751.3825	   5926.62	   4.3375	  
	   	  1320.57	   768.2	   *	   1320.7691	   768.3991	   7886.31	   0.1991	  
	  
EGWLHK	  
1440.11	   887.74	  
	  
1447.8246	   895.4546	   6406.74	   7.7146	  
	   	  1475.16	   922.79	  
	  
1477.9158	   925.5458	   10131.17	   2.7558	  
	   	  1493.13	   940.76	  
	  
1477.9158	   925.5458	   9276.21	   15.2142	  
	   	  1499.13	   946.76	  
	  
1507.814	   955.444	   4112.05	   8.684	  
	   	  1515.1	   962.73	  
	  
1507.814	   955.444	   4687.71	   7.286	  
	   	  1567.65	   1015.28	  
	  
1565.8591	   1013.489	   7907.73	   1.7909	  
	   	  1639.2	   1086.83	  
	  
1645.9403	   1093.57	   21961.13	   6.7403	  
	   	  1707.53	   1155.16	  
	  
1701.0101	   1148.64	   12923.9	   6.5199	  
	   	  1791.09	   1238.72	  
	  
1795.9606	   1243.591	   5200.25	   4.8706	  
	   	  1802.79	   1250.42	  
	  
1800.0105	   1247.641	   8149.76	   2.7795	  
	   	  1851.79	   1299.42	  
	  
1841.9813	   1289.61	   4331.77	   9.8087	  
	   	  1995.47	   1443.1	  
	  
1957.1459	   1404.78	   4368.22	   38.3241	  
	   	  2212.04	   1659.67	   *	   2213.208	   1660.838	   95735.94	   1.168	  
	  
EEWTTAIQTVADGLK	  
2225.51	   1673.14	  
	  
2213.208	   1660.838	   17712.89	   12.302	  
	   	  2233.95	   1681.58	  
	  
2213.208	   1660.838	   12256.12	   20.742	  
	   	  2284.12	   1731.75	  
	  
2344.242	   1791.872	   5711.7	   60.122	  
	   	  2306.92	   1754.55	  
	  
2344.242	   1791.872	   6553.24	   37.322	  
	   	  2344.23	   1791.86	   *	   2344.242	   1791.872	   4506.1	   0.012	  
	  
EAPLNNFSVAQCQLMK	  
2383.46	   1831.09	  
	  
2362.2571	   1809.887	   8608.79	   21.2029	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Table	  S4:	  Hit	  Sequences	  from	  Biligand	  Screen	  
Az4	   h	   w	   p	   r	  
Az4	   n	   v	   y	   l	  
Az4	   h	   y	   r	   w	  
Az4	   r	   d	   y	   r	  
Az4	   y	   n	   y	   k	  
Az4	   y	   k	   t	   w	  
Az4	   s	   r	   f	   y	  
Az4	   y	   k	   s	   y	  
Az4	   y	   y	   s	   r	  
Az4	   r	   h	   w	   s	  
Az4	   p	   w	   w	   r	  
Az4	   n	   f	   r	   y	  
Az4	   y	   w	   r	   l	  
Az4	   y	   w	   k	   G	  
Az4	   a	   y	   l	   y	  
Az4	   h	   w	   r	   w	  
Az4	   n	   w	   r	   l	  
Az4	   a	   a	   r	   w	  
Az4	   G	   r	   w	   y	  
Az4	   w	   f	   r	   i	  
Az4	   r	   p	   y	   y	  
Az4	   v	   w	   f	   r	  
	  
Table	  S5:	  Hit	  Sequences	  from	  Triligand	  Screen	  
G	   l	   -­‐	   -­‐	   m	   -­‐	  
i	   r	   y	   r	   n	   Pra	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Table	  S4:	  Hit	  Sequences	  from	  Biligand	  Screen	  
Az4	   h	   w	   p	   r	  
Az4	   n	   v	   y	   l	  
Az4	   h	   y	   r	   w	  
Az4	   r	   d	   y	   r	  
Az4	   y	   n	   y	   k	  
Az4	   y	   k	   t	   w	  
Az4	   s	   r	   f	   y	  
Az4	   y	   k	   s	   y	  
Az4	   y	   y	   s	   r	  
Az4	   r	   h	   w	   s	  
Az4	   p	   w	   w	   r	  
Az4	   n	   f	   r	   y	  
Az4	   y	   w	   r	   l	  
Az4	   y	   w	   k	   G	  
Az4	   a	   y	   l	   y	  
Az4	   h	   w	   r	   w	  
Az4	   n	   w	   r	   l	  
Az4	   a	   a	   r	   w	  
Az4	   G	   r	   w	   y	  
Az4	   w	   f	   r	   i	  
Az4	   r	   p	   y	   y	  
Az4	   v	   w	   f	   r	  
	  
Table	  S5:	  Hit	  Sequences	  from	  Triligand	  Screen	  
G	   l	   -­‐	   -­‐	   m	   -­‐	  
i	   r	   y	   r	   n	   Pra	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